{

    "tests": [
        {
            "id": 1,
            "name": "Hematocrit",
            "localCode": "123",
            "loinc": {
                "class": "medilabcore.LOINC",
                "id": 1,
                "code": "58410-2",
                "component": "Complete blood count (hemogram) panel ",
                "longName": "Complete blood count (hemogram) panel in Blood by Automated count",
                "method": "Automated count",
                "name": "Complete blood count (hemogram) panel ",
                "property": "- [Mixed properties (Panels only)] ",
                "scale": "-",
                "shortName": "CBC",
                "system": "Bld [Blood]",
                "time": "Pt [Point in time (spot)]"
            },
            "collectionTime": "From 8am to 12 pm",
            "servicePromise": "72 hours",
            "lexiCompLab": {
                "class": "medilabcore.LexiCompLab",
                "id": 1,
                "chapterId": "781",
                "chapterName": "Hematology",
                "chapterSections": "null",
                "chapterViewId": "5561",
                "mono": " <mono id=\"382423\" globalid=\"42126\" docName=\"Complete Blood Count\" createdDate=\"2006-03-15\"\n modifiedDate=\"2011-11-17\">\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746900\" class=\"block nam\">Complete Blood Count</div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746912\" class=\"sec_xr rftlist\">\n <ul>\n <li>\n <a href=\"urn:lims:s382452\">Complete Blood Count Differential and Peripheral Smear</a>\n </li>\n <li>\n <a href=\"urn:lims:s382460\">Reticulocyte Count</a>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746905\" class=\"block ovv\">\n <p style=\"text-indent:0em;display:inline\">The complete blood cell count (CBC) is a profile of tests\n rather than a single test. It is the standard, broadly inclusive, usually automated test for\n evaluation of white blood cells (WBC), red blood cells (RBC), and platelets (Plt). Complete blood\n count is among the most commonly ordered tests as it provides an overview of a patient's general\n health status.\n </p>\n <p style=\"text-indent:0em;margin-top:2em;\">Total white blood cell count (WBC) includes neutrophils (also\n known as polymorphonuclear cells, or PMNs), lymphocytes, monocytes, basophils, and eosinophils. The\n results help in the diagnosis and monitoring of infections, neoplastic conditions, and immunologic\n disease states. WBCs are measured in parts per cubic mm (mm<sup>3</sup>) and often expressed as (x\n 10<sup>9</sup>/L).\n </p>\n <p style=\"text-indent:0em;margin-top:2em;\">Hemoglobin (Hgb) and hematocrit (Hct), also known as the H&amp;H,\n help to assess oxygen carrying capacity. Hgb is a measurement of the oxygen-carrying protein in rbcs\n and is measured as g/dL. Hct, or packed red cell volume, is the percent of red cells contained in\n whole blood. It is typically three times the Hgb when RBCs are of normal size and contain normal\n amounts of hemoglobin.\n </p>\n <p style=\"text-indent:0em;margin-top:2em;\">Platelet count (Plt) helps assess bleeding, thrombotic, and\n neoplastic processes. It assists in the evaluation of bone marrow function, as well as the study of\n some diseases involving autoimmune mechanisms. Platelets are measured in parts per cubic mm (mm<sup>\n 3</sup>) and often expressed as (x 10<sup>9</sup>/L).\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746916\" class=\"block use\">\n <p style=\"text-indent:0em;\">\n <i>WBC:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Reaction to bacterial and viral infections</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Reaction to inflammation</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Evaluate myelopoiesis</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Diagnose/evaluate leukemic states</p>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Hgb and Hct:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Evaluate the adequacy of oxygen delivery to the tissues as is\n relates to hematologic (as opposed to cardiopulmonary) factors\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Evaluate state of hydration and dehydration</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify anemia</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify polycythemia</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify hemolytic disease of the newborn</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Manage chemotherapy decisions</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Provide the basis for calculations of blood cellular characteristics\n (MCV, MCH, MCHC, RDW) that reflect RBC size and shape, and which provide clues to the\n diagnosis of a variety of hematologic conditions (eg, anemia) (refer to Interpretative\n Information below)\n </p>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Platelets:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Evaluate, diagnose, and follow up bleeding disorders</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Evaluate purpura/petechiae</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify drug-induced thrombocytopenia</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify idiopathic thrombocytopenic purpura (ITP)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify disseminated intravascular coagulation (DIC)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Evaluate hypercoagulable states</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Manage chemotherapeutic decisions</p>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746904\" class=\"block tei\">\n <p style=\"text-indent:0em;display:inline\">White blood cell count (WBC); red blood cell count (RBC);\n hemoglobin (Hgb); hematocrit (Hct); mean corpuscular volume (MCV); mean corpuscular hemoglobin\n concentration (MCHC); red cell distribution (RDW); platelet count (Plt); mean platelet volume (MPV)\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746908\" class=\"block spe\">\n <p style=\"text-indent:0em;display:inline\">3 mL whole blood (2 mL minimum), usually peripheral</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746909\" class=\"block con\">\n <p style=\"text-indent:0em;display:inline\">Lavender top (EDTA) tube</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10070413\" class=\"block tec\">\n <p style=\"text-indent:0em;display:inline\">Primarily performed using automated equipment to analyze a\n simple venipuncture sample collected in a universal lavender (or purple) top tube containing EDTA as\n an anticoagulant.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746910\" class=\"block col\">\n <p style=\"text-indent:0em;display:inline\">Mix specimen 10 times by gentle inversion. If specimen is not\n brought to the laboratory immediately, refrigeration is required.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746911\" class=\"block sti\">\n <p style=\"text-indent:0em;display:inline\">EDTA-anticoagulated sample should be analyzed within 6 hours\n at room temperature and within 24 hours when stored at 4°C. Studies using the Cell-Dyn 3500 (Abbott\n Diagnostics, Mountain View, CA) found blood cell parameters stable for up to 24-48 hours\n (differential stable for 24 hours) at 4°C.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746918\" class=\"block met\">\n <p style=\"text-indent:0em;display:inline\">Varies considerably between institutions. Most laboratories\n have commercial high capacity multichannel instruments. The majority measure RBC and WBC parameters\n on the basis of changes in electrical impedance as cells and platelets are pulled through a tiny\n aperture. Some instruments count impulses as cells flow across a laser beam. These are highly\n automated devices with extensive computer processing of the electrical signals after analog/digital\n conversion. Accuracy (with proper standardization) and precision (usually in the 0.5% to 2% range)\n is significantly improved over older manual and semiautomated methods. Proper calibration is very\n important. Excellent correlation for all parameters (except basophils) has been shown across a wide\n spectrum of instruments.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10070416\" class=\"block daa\">\n <ul>\n <li>\n <p style=\"text-indent:0em;\">WBC</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">WBC 5-part differential: neutrophils, monocytes, lymphocytes,\n eosinophils, basophils\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RBC: Hct, Hgb</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RBC indices that describe the size and oxygen-carrying protein\n (hemoglobin) content of red blood cells and are used in the classification and diagnosis of\n anemia:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">MCV − mean corpuscular volume, most commonly used index</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RDW − red blood cell distribution width</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCHC − mean corpuscular hemoglobin concentration</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCH − mean corpuscular hemoglobin</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Platelet count</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Platelet indices that allow differentiation between hyperdestructive\n and hypoproliferative thrombocytopenia:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">PDW − platelet distribution width</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MPV − mean platelet volume</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Reticulocyte count and indices (not typically reported without a\n specific order to do so)\n </p>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746915\" class=\"block nof\">\n <p style=\"text-indent:0em;\">\n <i>WBC</i>\n (adults): 4.5-11.0 x 10<sup>9</sup>/L:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Diurnal variation present with lowest WBC level in morning and\n maximum level in afternoon\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">High levels of activity, emotional stress, or exercise (each\n associated with release of endogenous steroids) may increase WBC count, with increases of\n 2.0-5.0 x 10<sup>9</sup>/L common, and rises up to 30 x 10<sup>9</sup>/L possible\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">African-Americans individuals have consistently lower mean WBC\n counts than caucasians:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">0.6-1.3 x 10<sup>9</sup>/L lower on average between males\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">0.2-1.4 x 10<sup>9</sup>/L lower on average between females\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">WBC differential (adults):</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Neutrophils: 40% to 60%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Lymphocytes: 20% to 40%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Monocytes: 2% to 8%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Eosinophils: 1% to 4%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Basophils: 0.5% to 1%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Bands (young neutrophils): 0% to 3%</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <a href=\"http://www.pediatriccareonline.org/pco/ub/view/Pediatric-Drug-Lookup/153930/0/Normal_Laboratory_Values_for_Children\"\n target=\"_blank\">WBC normal values\n </a>\n for adults, young children, and infants can vary significantly.\n </p>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Hgb and Hct:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Adult female: 12-16 g/dL</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Adult male: 14-18 g/dL</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Males have consistently higher values than females</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Adults have\n <a href=\"http://www.pediatriccareonline.org/pco/ub/view/Pediatric-Drug-Lookup/153930/0/Normal_Laboratory_Values_for_Children\"\n target=\"_blank\">higher values\n </a>\n than children (except neonates, which have the highest values of all)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Red blood cell indices:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">MCV: 80–96 fL</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCH: 27–33 pg</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCHC: 33% to 36%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RDW: 12% to 15%</p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Platelets:</i>\n 150-450 x 10<sup>9</sup>/L\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746914\" class=\"block crv\">\n <p style=\"text-indent:-2em;margin-left:4em;\">• WBC: &lt;2.5 x 10<sup>9</sup>/L or &gt;30 x 10<sup>\n 9</sup>/L\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;\">• Hemoglobin: &lt;6.0 g/dL or &gt;18.0 g/dL</p>\n <p style=\"text-indent:-2em;margin-left:4em;\">• Hematocrit: &lt;18% or &gt;54%</p>\n <p style=\"text-indent:-2em;margin-left:4em;\">• Platelets: &lt;20 x 10<sup>9</sup>/L or &gt;1000 x 10\n <sup>9</sup>/L\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10070417\" class=\"block interp-info\">\n <p style=\"text-indent:0em;\">\n <b>\n <i>WBC</i>\n </b>\n differential assists in:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Diagnosing bacterial infections (elevated WBC, often with\n predominance of neutrophils)\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">“Left shift” refers to the presence of increased numbers of\n mature neutrophils and immature neutrophil 'band' forms. May also be seen as a\n result of demargination due to physiologic stress or steroids.\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">&gt;75 % neutrophils</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">&gt;8% to 10% bands</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">&gt;7000 absolute neutrophil count (ANC) [(percent\n neutrophil) x (total WBC)]\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Diagnosing viral infections (decreased WBC, often with a\n predominance of lymphocytes)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Diagnosing malignancy such as leukemia (disproportionate\n number of one cell type, or a surplus of immature or 'blast' cells)\n </p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <b>\n <i>Red cell indices</i>\n </b>\n assist in diagnosing the underlying cause of anemia.\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">\n <i>MCV:</i>\n Mean corpuscular volume\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Most commonly used RBC index</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Reflects the average red blood cell size</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Calculated by dividing the hematocrit by the red blood cell\n count (number of red blood cells per liter)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Expressed in femtoliters per red cell (1 fL = 10\n <sup>-15</sup>\n L)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Categorizes red blood cells by size which is used to\n classify anemias:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Normocytic: Cells of normal size</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Microcytic: Cells smaller than normal size</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Macrocytic: Cells larger than normal size</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Increased with B\n <sub>12</sub>\n and folate deficiency; decreased with iron deficiency and thalassemia\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>MCH:</i>\n Mean corpuscular hemoglobin\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Hemoglobin amount per red blood cell</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCH = Hgb / RBC count</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Expressed in picograms per red cell (1 pg = 10\n <sup>-12</sup>\n g)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Mirrors MCV results</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>MCHC:</i>\n Mean corpuscular hemoglobin concentration\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Amount of hemoglobin relative to the size of the red blood\n cell\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCHC = Hgb/Hct</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Expressed in grams per red cell (g/L)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Relates to the color of the cells which is used to classify\n anemias:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Normochromic: Cells with a normal concentration of\n Hgb\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Hypochromic: Cells with a lower than normal\n concentration, typically lighter in color with a large pale center\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <b>No</b>\n hyperchromic category as there is a physical limit to the amount of Hgb that\n will fit inside a RBC\n </p>\n </li>\n </ul>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>RDW:</i>\n RBC distribution width\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Measure of the variation of red blood cell size within a\n population\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Increased RDW indicates a mixed population of sizes</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Healthy blood cells are of a standard size, while in anemia\n and other disorders significant variation in cell size can occur\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RDW = standard deviation of erythrocyte volume distribution\n / MCV\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RDW results are often used together with MCV results to\n determine the cause of anemia, and are particularly helpful in differentiating an\n anemia of mixed causes from an anemia of a single cause.\n </p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;margin-top:2em;\"></p>\n <table rules=\"all\" border=\"1\" frame=\"border\">\n <caption style=\"text-align:center;\">Changes in RBC Indices With Disease</caption>\n <col align=\"left\" width=\"230\"/>\n <col align=\"center\" width=\"60\"/>\n <col align=\"center\" width=\"90\"/>\n <col align=\"center\" width=\"60\"/>\n <col align=\"center\" width=\"60\"/>\n <thead valign=\"bottom\">\n <tr>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Condition</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">MCV</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">MCH</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">MCHC</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">RDW</p>\n </th>\n </tr>\n </thead>\n <tfoot valign=\"top\">\n <tr>\n <td colspan=\"5\" align=\"left\">\n <p style=\"text-indent:0em;\">N=normal values</p>\n </td>\n </tr>\n </tfoot>\n <tbody valign=\"top\">\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Iron deficiency anemia</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Chronic inflammation</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Pernicious anemia</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N or high N</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">high N</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">B\n <sub>12</sub>\n / folate deficiency\n </p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N or high N</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">high N</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Hereditary spherocytosis</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N or ↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Hemolytic / aplastic anemia</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Anemia secondary to acute blood loss</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Polycythemia</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\">\n <p style=\"text-indent:0em;\">Hemochromatosis</p>\n </td>\n <td align=\"center\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n </tbody>\n </table>\n <div class=\"text_table\">\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Table has been converted to the\n following text.\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:center;\">\n <b>Changes in RBC Indices With Disease</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Iron deficiency anemia:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Increased</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Chronic inflammation:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Pernicious anemia:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal or high normal</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: High normal</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Increased</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>B\n <sub>12</sub>\n / folate deficiency:\n </b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal or high normal</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: High normal</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Increased</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Hereditary spherocytosis:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Normal or decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Hemolytic / aplastic anemia:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Anemia secondary to acute blood loss:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Polycythemia:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Hemochromatosis:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n </div>\n <p style=\"text-indent:0em;\">\n <b>\n <i>Platelet indices</i>\n </b>\n allow differentiation between hyperdestructive and hypoproliferative thrombocytopenia:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">\n <i>PDW:</i>\n Platelet distribution width\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Measure of the variation of platelet size within a\n population, which can be a sign of active platelet release\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Indicates whether platelets are normally distributed, and\n whether the measured cells are platelets at all\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>MPV:</i>\n Mean platelet volume\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Average size of platelets</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Elevated level indicates increased megakaryocyte shedding of\n platelets; decreased level seen in thrombocytopenia\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Significantly elevated MPV may indicate that production and/or\n destruction of platelets are increased, such as in ITP or leukemia\n </p>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746917\" class=\"block lim\">\n <p style=\"text-indent:0em;\">\n <i>WBC:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Falsely high WBC may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Presence of cryoglobulins/cryofibrinogen</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">EDTA-induced platelet aggregation or clumping (large clumps\n mistaken as WBCs)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Fibrin strands</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Presence of nucleated red blood cells</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Nonlysed red cells (eg, some cases of hemoglobinopathy)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Monoclonal proteins</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Cold agglutinins</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Capillary blood samples (may give WBC count 3% to 12% higher\n values than venous blood)\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Falsely low WBC counts may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Microclots or partial clotting of the specimen</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Loss of cell integrity due to prolonged storage</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Presence of fragile (apoptotic) white cells (eg, some cases\n of myelodysplastic syndrome)\n </p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Hemoglobin:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Falsely high Hgb may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Lipemic plasma, especially if chylomicronemia is present</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">White count is &gt;50 x 10<sup>9</sup>/L\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Falsely low Hgb may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Cold agglutinins which may cause spurious macrocytosis and\n low RBC count (RBC couplets are “seen” and processed as single cells by the\n detection circuitry)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Capillary blood samples (may give platelet count 3% to 12%\n lower values than venous blood)\n </p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Hematocrit:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Falsely high Hct may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Presence of cryoproteins</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">White count is &gt;50 x 10<sup>9</sup>/L\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Giant platelets (miscounted as RBCs)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">“Spun” (manual centrifuged) microhematocrits are ~3% higher\n (due to plasma trapping) compared to automated hematocrit levels\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Especially pronounced in polycythemia</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Accentuated when the cells are hypochromic and\n microcytic\n </p>\n </li>\n </ul>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Falsely low Hct may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Microcytosis</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>In vitro</i>\n hemolysis\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Presence of autoagglutinins</p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Platelets:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Falsely high Plt may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Cryoproteinemia (cryoglobulinemia)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Hypertriglyceridemia (May cause increase in platelets of\n 2-40 x 10<sup>9</sup>/L, which can become significant with low platelet numbers)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RBC or WBC fragments including fragmented fragile leukemic\n cells and neutrophil pseudoplatelets\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Falsely low Plt may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">EDTA-induced platelet clumping</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Platelet satellitism around neutrophils</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Various platelet antigen/antibody reactions including\n antiplatelet with antiphospholipid antibodies (eg,\n <i>in vitro</i>\n clumping of IgM autoantibody against 78 kD platelet glycoprotein)\n </p>\n </li>\n </ul>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746913\" class=\"block cfr\">\n <p style=\"text-indent:0em;display:inline\">Improper tube; clotted specimen; hemolyzed specimen; dilution\n of blood with I.V. fluid\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746903\" class=\"list synlist\">\n <ul>\n <li>Blood Cell Profile</li>\n <li>Blood Count</li>\n <li>CBC</li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10070419\" class=\"list aptlist\">\n <ul>\n <li>H and H</li>\n <li>H&amp;H</li>\n <li>H+H</li>\n <li>Hemoglobin and Hematocrit</li>\n <li>Hemogram</li>\n <li>Hgb and Hct</li>\n <li>Leukocyte Count</li>\n <li>MCH</li>\n <li>MCHC</li>\n <li>MCV</li>\n <li>Mean Corpuscular Hemoglobin</li>\n <li>Mean Corpuscular Hemoglobin Concentration</li>\n <li>Mean Corpuscular Volume</li>\n <li>Mean Platelet Volume</li>\n <li>MPV</li>\n <li>PDW</li>\n <li>Platelet Count</li>\n <li>Platelet Volume Distribution</li>\n <li>RBC</li>\n <li>RDW</li>\n <li>Red Blood Cell Indicies</li>\n <li>Red Cell Count</li>\n <li>Red Cell Distribution Width</li>\n <li>Thrombocyte Count</li>\n <li>WBC</li>\n <li>White Blood Count</li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746921\" class=\"block rfs\">\n <div class=\"reference\">American Academy of Pediatrics, “Normal Laboratory Values for Children,”\n http://www.pediatriccareonline.org/pco/ub/view/Pediatric-Drug-Lookup/153930/0/Normal_Laboratory_Values_for_Children\n (accessed 02/22/2010).\n </div>\n <div class=\"reference\">Bagby GC, “Leukopenia and Leukocytosis,”<i>Cecil Medicine</i>, 23rd ed, Chapter\n 173, Goldman L and Ausiello D, eds, Philadelphia, Pa: Saunders Elsevier, 2007.\n </div>\n <div class=\"reference\">Briggs C, “Quality Counts: New Parameters in Blood Cell Counting,”<i>Int J Lab\n Hematol</i>, 2009, 31(3):277-97.\n <span class=\"pubmed-id\">19452619</span>\n </div>\n <div class=\"reference\">Cheng CK, Chan J, Cembrowski GS, et al, “Complete Blood Count Reference Interval\n Diagrams Derived From NHANES III: Stratification by Age, Sex, and Race,”<i>Lab Hematol</i>, 2004,\n 10(1):42-53.\n <span class=\"pubmed-id\">15070217</span>\n </div>\n <div class=\"reference\">Gulati GL and Hyun BH, “The Automated CBC: A Current Perspective,”<i>Hematol\n Oncol Clin North Am</i>, 1994, 8(4):593-603.\n <span class=\"pubmed-id\">7961282</span>\n </div>\n <div class=\"reference\">Hoyer JD, “Leukocyte Differential,”<i>Mayo Clin Proc</i>, 1993, 68(10):1027-8.\n <span class=\"pubmed-id\">8412355</span>\n </div>\n <div class=\"reference\">Kjeldsberg CR, Elenitoba-Johnson K, Foucar K, et al,<i>Practical Diagnosis of\n Hematologic Disorders</i>, 3rd ed, Kjeldsberg CR, ed, Chicago, IL: ASCP Press, 2000.\n </div>\n <div class=\"reference\">“Laboratory Methods,”<i>Clinical Hematology and Fundamentals of Hemostasis</i>,\n 4th ed, Part V, Harmening DM, ed, Philadelphia, PA: FA Davis Co, 2002, 563-614.\n </div>\n <div class=\"reference\">Oosterhuis WP, Niessen RW, Bossuyt PM, et al, “Diagnostic Value of the Mean\n Corpuscular Volume in the Detection of Vitamin B\n <sub>12</sub>\n Deficiency,”<i>Scand J Clin Lab Invest</i>, 2000, 60(1):9-18.\n </div>\n <div class=\"reference\">Shapiro MF and Greenfield S, “The Complete Blood Count and Leukocyte Differential\n Count. An Approach to Their Rational Application,”<i>Ann Intern Med</i>, 1987, 106(1):65-74.\n <span class=\"pubmed-id\">3538968</span>\n </div>\n <div class=\"reference\">Sheridan BL, Lollo M, Howe S, et al, “Evaluation of the Roche Cobas Argos 5Diff\n Automated Haematology Analyzer With Comparison to a Coulter STK-S,”<i>Clin Lab Haematol</i>, 1994,\n 16(2):117-30.\n <span class=\"pubmed-id\">7955920</span>\n </div>\n <div class=\"reference\">“The Blood Count,”<i>Advanced Laboratory Methods in Haematology</i>, Part 1,\n Rowan RM, van Assendelft OW, and Preston FE, eds, London, UK: Arnold, 2002, 254.\n </div>\n </div>\n </mono>",
                "monoCreatedDate": "2006-03-15",
                "monoDocName": "Complete Blood Count",
                "monoGlobalId": "42126",
                "monoId": "382423",
                "monoModifiedDate": "2011-11-17",
                "test": [
                    {
                        "class": "Test",
                        "id": 3
                    },
                    {
                        "class": "Test",
                        "id": 1
                    }
                ],
                "title": "Hematology"
            },
            "labTestsOnline": [
                {
                    "name": "Hematocrit",
                    "synonyms": "Hct; Crit; Packed cell volume; PCV; H and H (Hemoglobin and Hematocrit)",
                    "relatedTests": "Complete Blood Count, Hemoglobin, RBC Count, Blood Smear, Iron Tests,\nReticulocyte Count, Vitamin B12 and Folate, Red Cell Indices,\n Bone Marrow Aspiration and Biopsy, G6PD, Erythropoietin, Hemoglobin Variants",
                    "patientGeneralInfo": "Why Get Tested?\nTo determine the proportion of your blood that is made up of red blood cells (RBCs), thus to screen for, help diagnose, or monitor conditions that affect RBCs; as part of a routine health examination or if your doctor suspects that you have anemia or polycythemia\n\nWhen to Get Tested?\nWith a test for hemoglobin or as part of a complete blood count (CBC) during a routine health exam or when your doctor suspects you have a condition such as anemia (low hematocrit) or polycythemia (high hematocrit); at regular intervals to monitor a disorder that affects RBCs and to evaluate treatment effectiveness\n\nSample Required?\nA blood sample drawn from a vein in your arm or by a fingerstick (children and adults) or heelstick (newborns)\n\nTest Preparation Needed?\nNone",
                    "patientTestSample": "What is being tested?\nBlood consists of a few types of cells, including red blood cells (RBCs), white blood cells (WBCs), and platelets, suspended in a fluid portion called plasma. A hematocrit is a test that measures the proportion of a person's blood that is made up of RBCs. It is a ratio of the volume of red blood cells to the volume of whole blood. The value is expressed as a percentage or fraction. For example, a hematocrit value of 40% means that there are 40 milliliters of red blood cells in 100 milliliters of blood.\n\nThe hematocrit is a fairly quick and simple way of evaluating a person's red blood cells. It is often performed in conjunction with a hemoglobin level and is also one component of the complete blood count (CBC), a test that is often used in the general evaluation of a person's health.\n\nRBCs are produced in the bone marrow and are released into the bloodstream after they mature. They typically make up roughly 37% to 49% of the volume of blood. RBCs contain hemoglobin, a protein that binds to oxygen. The primary function of RBCs is to carry oxygen from the lungs to the tissues and organs of the body. They also transport a small portion of carbon dioxide, a byproduct of cell metabolism from tissues and organs back to the lungs, where it is expelled. The bone marrow must continually produce new RBCs to replace those that age and degrade or are lost through bleeding. The typical lifespan of an RBC is 120 days. There are a number of conditions that can affect either the production of new RBCs or the lifespan of those in circulation or that result in significant bleeding.\n\nThe hematocrit reflects both the number of red cells and their volume (mean corpuscular volume or MCV). If the size of the red cells decreases, so will the hematocrit and vice versa. In general, the hematocrit will rise when the number of red blood cells increases and the hematocrit will fall to less than normal when there is a drop in production of RBCs by the bone marrow, an increase in the destruction of RBCs, or if blood is lost due to bleeding. A drop in the RBC count, hemoglobin and hematocrit can result in anemia, a condition in which the body does not have the capacity to deliver enough oxygen to tissues and organs, causing fatigue and weakness. If too many RBCs are produced (resulting in increased hematocrit), then the blood can become thickened, causing sluggish blood flow and related problems.\n\nHow is the sample collected for testing?\nA sample is obtained by drawing blood through a needle placed in a vein in the arm or by a fingerstick (for children and adults) or a heelstick (for newborns).\n\nNOTE: If undergoing medical tests makes you or someone you care for anxious, embarrassed, or even difficult to manage, you might consider reading one or more of the following articles: Coping with Test Pain, Discomfort, and Anxiety, Tips on Blood Testing, Tips to Help Children through Their Medical Tests, and Tips to Help the Elderly through Their Medical Tests.\n\nAnother article, Follow That Sample, provides a glimpse at the collection and processing of a blood sample and throat culture.\n\nIs any test preparation needed to ensure the quality of the sample?\nNo test preparation is needed.",
                    "theTest": "How is it used?\nThe hematocrit may be used to screen for, diagnose, or monitor a number of conditions and diseases that affect the proportion of the blood made up of red blood cells (RBCs). It is often used with a hemoglobin level as a simple and quick evaluation of RBCs or is performed as part of a complete blood count (CBC) as an integral part of a health evaluation. The test may be used to:\n\nScreen for, diagnose, and evaluate the severity of anemia (low RBCs, low hemoglobin, low hematocrit) or polycythemia (high RBCs, high hemoglobin, high hematocrit)\nMonitor the response to treatment of anemia or polycythemia and other disorders that affect RBC production or lifespan\nHelp make decisions about blood transfusions or other treatments if the anemia is severe\nEvaluate dehydration\nSome conditions affect RBC production in the bone marrow and may cause an increase or decrease in the number of mature RBCs released into the blood circulation. Other conditions may affect the lifespan of RBCs in the circulation. If there is increased destruction of RBCs (hemolysis) or loss of RBCs (bleeding) and/or the bone marrow is not able to produce new ones fast enough, then the overall number of RBCs and hematocrit will drop, resulting in anemia.\n\nThis test can indicate if there is a problem with red blood cell production and/or lifespan, but it cannot determine the underlying cause. In addition to the full CBC, some other tests that may be performed at the same time or as follow up to establish a cause include a blood smear, reticulocyte count, iron studies, vitamin B12 and folate levels, and in more severe conditions, a bone marrow examination.\n\n^ Back to top\n\nWhen is it ordered?\nThe hematocrit is routinely ordered as a part of the complete blood count (CBC). It may also be ordered by itself or with a hemoglobin level as part of a general health examination. These tests are often ordered when a person has signs and symptoms of a condition affecting RBCs, such as anemia and polycythemia.\n\nSome signs and symptoms of anemia include:\n\nWeakness or fatigue\nLack of energy\nFainting\nPaleness (pallor)\nShortness of breath\nSome signs and symptoms of polycythemia include:\n\nDisturbed vision\nDizziness\nHeadache\nFlushing\nEnlarged spleen\nIt may sometimes be ordered when someone has signs and symptoms of serious dehydration, such as extreme thirst, dry mouth or mucous membranes, and lack of sweating or urination.\n\nThis test may be performed several times or on a regular basis when someone has been diagnosed with ongoing bleeding problems or chronic anemias or polycythemia to determine the effectiveness of treatment. It may also be ordered routinely on patients undergoing treatment for cancer that is known to affect the bone marrow.\n\n^ Back to top\n\nWhat does the test result mean?\nRed blood cells typically make up roughly 37% to 49% of the volume of blood.\n\nSince a hematocrit is often performed as part of a CBC, results from other components are taken into consideration. A rise or drop in the hematocrit must be interpreted in conjunction with other parameters, such as RBC count, hemoglobin, reticulocyte count and/or red blood cell indices. Age, gender, and race are other factors to be considered. In general, the hematocrit mirrors the results of the RBC count and hemoglobin.\n\nSome causes of a low hematocrit include:\n\nExcessive destruction of red blood cells, for example, hemolytic anemia caused by autoimmunity or defects in the red cell itself; the defects could be hemoglobinopathy (e.g., sickle cell anemia), abnormalities in the RBC membrane (e.g., hereditary spherocytosis) or RBC enzyme (e.g., G6PD deficiency)\nDecreased production of hemoglobin (e.g., thalassemia)\nAcute or chronic bleeding from the digestive tract (e.g., ulcers, polyps, colon cancer) or other sites, such as the bladder, uterus (in women, heavy menstrual bleeding, for example), or from severe trauma\nNutritional deficiencies such as iron, folate or B12 deficiency\nDamage to the bone marrow from, for example, a toxin, radiation or chemotherapy, infection or drugs\nKidney failure—severe and chronic kidney diseases lead to decreased production of erythropoietin, a hormone produced by the kidneys that stimulates RBC production by the bone marrow.\nChronic inflammatory diseases or conditions\nBone marrow disorders such as aplastic anemia, myelodysplastic syndrome, or cancers such as leukemia, lymphoma, multiple myeloma, or other cancers that spread to the marrow\nSome causes of a high hematocrit include:\n\nDehydration—this is the most common cause of a high hematocrit. As the volume of fluid in the blood drops, the RBCs per volume of fluid artificially rises; with adequate fluid intake, the hematocrit returns to normal.\nPolycythemia vera—a rare disease in which the body produces excess RBCs inappropriately\nLung (pulmonary) disease—if someone is unable to breathe in and absorb sufficient oxygen, the body tries to compensate by producing more red blood cells.\nCongenital heart disease—in some forms, there is an abnormal connection between the two sides of the heart, leading to reduced oxygen levels in the blood. The body tries to compensate by producing more red blood cells.\nKidney tumor that produces excess erythropoietin\nSmoking\nLiving at high altitudes (a compensation for decreased oxygen in the air)\nGenetic causes (altered oxygen sensing, abnormality in hemoglobin oxygen release)\n^ Back to top\n\nIs there anything else I should know?\nA recent blood transfusion will affect hematocrit results.\n\nPregnancy usually causes slightly decreased hematocrit values due to extra fluid in the blood.",
                    "commonQuestions": "1. Can my hematocrit be tested at home?\nNo. This test requires instrumentation and trained laboratory personnel.\n A hematocrit is typically indirectly measured (i.e., calculated from RBC and MCV)\n by automated hematology analyzers. It can also be directly measured by spinning a\n blood-filled capillary tube in a centrifuge (so-called spun hematocrit),\n but this manual method is less commonly used.\n\n2. Is anyone more at risk for abnormal hematocrit values? \nWomen of childbearing age tend to have lower hematorcit levels\n than men due to loss of iron and blood during menstrual periods and increased\n need for iron during pregnancy. People who have a chronic illness such as kidney\n disease, cancer, HIV/AIDS, chronic infection or autoimmune disorder (e.g., rheumatoid\n arthritis) are at risk for abnormally low hematocrits. Others who are at greater risk\n of a low hematocrit (anemia) include people with poor nutrition and diets low in iron\n or vitamins, people who have undergone surgery or have been severely injured.\n Someone who has family members with a genetic cause of anemia such as sickle cell\n or thalassemia also have a higher risk of having the condition and a higher risk of anemia."
                }
            ],
            "specialty": [
                {
                    "name": "Hematology"
                },
                {
                    "name": "Obstetrics"
                },
                {
                    "name": "Allergy and Immunology"
                },
                {
                    "name": "Rheumatology"
                },
                {
                    "name": "Cardiology"
                }
            ],
            "disease": [
                {
                    "name": "Liver disease"
                },
                {
                    "name": "Hyponatremia"
                },
                {
                    "name": "Diabetes"
                },
                {
                    "name": "Kidney disorders"
                }
            ],
            "condition": [
                {
                    "name": "Pregnancy"
                },
                {
                    "name": "Diabetes"
                },
                {
                    "name": "Osteoporosis"
                }
            ]
        },
        {
            "id": 2,
            "name": "Erythrocytes",
            "localCode": "128",
            "loinc": {
                "class": "medilabcore.LOINC",
                "id": 2,
                "code": "4544-3 ",
                "component": "Hematocrit",
                "longName": "Hematocrit [Volume Fraction] of Blood by Automated count",
                "method": "Automated count",
                "name": "Hematocrit",
                "property": "VFr",
                "scale": "Qn",
                "shortName": "Hematocrit",
                "system": "Bld",
                "time": "Pt"
            },
            "collectionTime": "From 6am to 10am",
            "servicePromise": "48 hours",
            "lexiCompLab": {
                "class": "medilabcore.LexiCompLab",
                "id": 2,
                "chapterId": "781",
                "chapterName": "Hematology",
                "chapterSections": "null",
                "chapterViewId": "5561",
                "mono": "<mono id=\"382436\" globalid=\"34963\" docName=\"Hemoglobin A&lt;sub&gt;2&lt;/sub&gt;\" createdDate=\"2006-03-15\"\n modifiedDate=\"2010-04-17\">\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747148\" class=\"block nam\">Hemoglobin A\n <sub>2</sub>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747156\" class=\"sec_xr rftlist\">\n <ul>\n <li>\n <a href=\"urn:lims:s382452\">Complete Blood Count Differential and Peripheral Smear</a>\n </li>\n <li>\n <a href=\"urn:lims:s382483\">DNA-Probe Assay for Thalassemia (BeTha Gene Test)</a>\n </li>\n <li>\n <a href=\"urn:lims:s146388\">Hematology / Anemia Flowchart</a>\n </li>\n <li>\n <a href=\"urn:lims:s382437\">Hemoglobin Electrophoresis</a>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747153\" class=\"block ovv\">\n <p style=\"text-indent:0em;display:inline\">Hemoglobin A\n <sub>2</sub>\n (Hb A<sub>2</sub>) is a tetramer of α- and δ-globulin chains (α\n <sub>2</sub>\n δ<sub>2</sub>). Concentration fluctuates in the thalassemia syndromes and some acquired diseases.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747159\" class=\"block use\">\n <p style=\"text-indent:0em;display:inline\">Investigate microcytic anemia, for hemoglobinopathies,\n especially thalassemia, particularly beta-thalassemia trait\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747162\" class=\"block coi\">\n <p style=\"text-indent:0em;display:inline\">Recent blood transfusion</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747154\" class=\"block spe\">\n <p style=\"text-indent:0em;display:inline\">Whole blood</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747155\" class=\"block con\">\n <p style=\"text-indent:0em;display:inline\">Lavender top (EDTA) tube</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747161\" class=\"block met\">\n <p style=\"text-indent:0em;display:inline\">Electrophoresis, DEAE cellulose chromatography, high\n performance cation-exchange liquid chromatography (HPLC); radial immunodiffusion (RID) has also been\n used. Capillary electrophoresis\n <sup class=\"footnote-number\">2</sup>\n and capillary isoelectric focusing have been developed\n <sup class=\"footnote-number\">3,4,5</sup>\n and found to be rapid (under 15 minutes), precise (coefficient of variation &lt;2% to 6%),\n sensitive, and high resolution automated methods for determination of Hb variants, comparable to the\n use of HPLC but with lower cost.\n <sup class=\"footnote-number\">4</sup>\n Hb A\n <sub>2</sub>\n by capillary electrophoresis was not affected by presence of Hb S\n <sup class=\"footnote-number\">5</sup>\n or Hb D\n <sup class=\"footnote-number\">6</sup>\n as has been reported to occur with use of HPLC-variant β-thalassemia short program.\n <sup class=\"footnote-number\">1</sup>\n One study concluded that the use of capillary zone electrophoresis at alkaline pH with “dynamic\n coating” (which increases negative charge on the capillary surface with resultant high\n electro-osmotic flow and shortens analysis time) could replace HPLC for the screening of\n hemoglobinopathies.\n <sup class=\"footnote-number\">7</sup>\n Due to these partly method-based interpretive difficulties, each laboratory should have and utilize\n an alternate procedure, the application and performance of which is understood.\n <sup class=\"footnote-number\">6</sup>\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747158\" class=\"block nof\">\n <p style=\"text-indent:0em;display:inline\">The stable adult Hb A\n <sub>2</sub>\n level is 2.0% to 3.2% of total hemoglobin; ≤5 months: 0% to 2.5%; 6 months to 1 year: 1.5% to 2.9%.\n See table.\n </p>\n <table rules=\"all\" border=\"1\" frame=\"border\">\n <caption>Alterations in Hb A\n <sub>2</sub>\n in Various Disorders\n </caption>\n <col align=\"left\" width=\"80\"/>\n <col width=\"210\"/>\n <col align=\"left\" width=\"160\"/>\n <thead valign=\"bottom\">\n <tr>\n <th align=\"center\" valign=\"middle\"/>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Elevated</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Reduced</p>\n </th>\n </tr>\n </thead>\n <tfoot valign=\"top\">\n <tr>\n <td colspan=\"3\" align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Adapted from Bunn HF and Forget BG,<i>Hemoglobin: Molecular,\n Genetic, and Clinical Aspects</i>, Philadelphia, PA: WB Saunders Co, 1986, 61-7.\n </p>\n </td>\n </tr>\n </tfoot>\n <tbody valign=\"middle\">\n <tr>\n <td align=\"left\" valign=\"middle\" rowspan=\"4\">\n <p style=\"text-indent:0em;\">Congenital</p>\n </td>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">β-thalassemia trait</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">α-thalassemia</p>\n </td>\n </tr>\n <tr>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">Unstable hemoglobin variants</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">δβ-thalassemia</p>\n </td>\n </tr>\n <tr>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">Sickle trait (AS)</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">δ-thalassemia</p>\n </td>\n </tr>\n <tr>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">SS with α-thalassemia</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">HPFH</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\" rowspan=\"2\">\n <p style=\"text-indent:0em;\">Acquired</p>\n </td>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">Megaloblastic anemias</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Iron deficiency</p>\n </td>\n </tr>\n <tr>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">Hyperthyroidism</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Sideroblastic anemias</p>\n </td>\n </tr>\n </tbody>\n </table>\n <div class=\"text_table\">\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Table has been converted to the\n following text.\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:center;\">\n <b>Alterations in Hb A\n <sub>2</sub>\n in Various Disorders\n </b>\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">\n <b>Congenital:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• Elevated: β-thalassemia trait;\n unstable hemoglobin variants; sickle trait (AS); SS with α-thalassemia\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• Reduced: α-thalassemia;\n δβ-thalassemia; δ-thalassemia; HPFH\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">\n <b>Acquired:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• Elevated: Megaloblastic anemias;\n hyperthyroidism\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• Reduced: Iron deficiency;\n sideroblastic anemias\n </p>\n <p style=\"text-indent:0em;\">Adapted from Bunn HF and Forget BG,<i>Hemoglobin: Molecular, Genetic,\n and Clinical Aspects</i>, Philadelphia, PA: WB Saunders Co, 1986, 61-7.\n </p>\n </div>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747160\" class=\"block lim\">\n <p style=\"text-indent:0em;display:inline\">Blood transfusion prior to hemoglobin electrophoresis may make\n interpretation inconsistent. High levels of hemoglobin F usually are accompanied by lower levels of\n A<sub>2</sub>. Sickle cell trait range is from 1.7% to 4.5% hemoglobin A<sub>2</sub>. Presence of Hb\n S or Hb C will interfere with column chromatographic method.\n <sup class=\"footnote-number\">1</sup>\n Presence of Hb C interferes with routine electrophoretic method. Quantitation of Hb A\n <sub>2</sub>\n by densitometric scanning of electrophoretic pattern may result in misleading (high) results as this\n method is not uniformly reliable.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747157\" class=\"block cfr\">\n <p style=\"text-indent:0em;display:inline\">Specimen clotted</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747163\" class=\"block adi\">\n <p style=\"text-indent:0em;display:inline\">This test is done in many laboratories as part of the\n hemoglobin electrophoresis. Hemoglobin A\n <sub>2</sub>\n levels have special application to the diagnosis of beta-thalassemia trait, which may be present\n even though peripheral blood smear is normal. This reflects the underlying genetic spectrum of\n beta-thalassemia which in reality is a complex of multiple distinct (and some less distinct)\n conditions, the result of over 180 different mutations.\n <sup class=\"footnote-number\">8</sup>\n The microcytosis and other morphologic changes of beta-thalassemia trait must be differentiated from\n iron deficiency. Low MCV may include the majority of beta-thalassemia trait patients but does not\n differentiate iron deficient individuals. Low Hb A\n <sub>2</sub>\n levels occur in untreated iron deficiency. If iron deficiency occurs with beta-thalassemia, the Hb A\n <sub>2</sub>\n level may fall to within the normal range.\n <sup class=\"footnote-number\">9</sup>\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">The most definitive evidence for presence\n of beta-thalassemia trait is genetic (family study). A well documented report, however, indicates\n the occurrence of beta-thalassemia minor as a result of a spontaneous initiation codon mutation.\n <sup class=\"footnote-number\">10</sup>\n Offspring of a person with thalassemia major will have beta-thalassemia trait. Apart from such\n family/genetic studies (which are subject to practical difficulties) gene probes are the most\n definitive method for identifying beta-thalassemia trait. This method identifies “silent” carriers.\n See<a href=\"urn:lims:s382483\">DNA-Probe Assay for Thalassemia (BeTha Gene Test)</a>. Elevated\n percent Hb A\n <sub>2</sub>\n is the next best evidence for the diagnosis of beta-thalassemia trait. Sufficient criteria for the\n diagnosis of thalassemia trait are an elevated Hb A\n <sub>2</sub>\n percentage by a reliable method (Hb electrophoresis with elution and quantitation by\n spectrophotometry) or column chromatography (assuming Hb S, C, or an unstable hemoglobin are not\n present).\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Hb A\n <sub>2</sub>\n may be increased in megaloblastic anemia and may be decreased in sideroblastic anemia, Hb H disease,\n and erythroleukemia. Approximately 33% of zidovudine (AZT) treated human immunodeficiency virus-1\n positive individuals have elevated Hb A\n <sub>2</sub>\n levels.\n <sup class=\"footnote-number\">11</sup>\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Hemoglobin is gradually lost from the red\n blood cell during its lifespan. During the first half of the red cell lifespan Hb A and Hb A\n <sub>2</sub>\n decrease by glycation and carbamylation. During the second half of the lifespan, additional Hb and\n chemically altered forms are lost, overall total loss of 20%.\n <sup class=\"footnote-number\">12</sup>\n Red cells lose water and Hb with age producing changes in the red cell indices (decrease of 30% in\n MCV, increase of 15% in MCHC).\n <sup class=\"footnote-number\">13</sup>\n In addition to changes in red cell indices, these considerations have clinical application to the\n efficacy (expected improvement in Hb/Hct level) of red cell transfusions.\n <sup class=\"footnote-number\">12</sup>\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">In a study of over 600 β-thalassemia\n heterozygotes (with multiple different underlying genetic mechanisms including 32 different base\n changes or frame shifts) severe cases (β°-thalassemia or β<sup>+</sup>-thalassemia) had Hb A\n <sub>2</sub>\n levels of 4.5% to 5.5%, mild β<sup>+</sup>-thalassemia had levels of 3.6% to 4.2%, while silent\n mutations had lower values. Homozygotes often had Hb A\n <sub>2</sub>\n levels of 10% or more but many cases had received transfusions such that A\n <sub>2</sub>\n values were not representative.\n <sup class=\"footnote-number\">14</sup>\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747151\" class=\"list synlist\">\n <ul>\n <li>Hb A\n <sub>2</sub>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747152\" class=\"list aptlist\">\n <ul>\n <li>Capillary Isoelectric Focusing</li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747164\" class=\"block foo\">\n <div class=\"footnote\">1. Shokrani M, Terrell F, Turner EA, et al, “Chromatographic Measurements of\n Hemoglobin A\n <sub>2</sub>\n in Blood Samples That Contain Sickle Hemoglobin,”<i>Ann Clin Lab Sci</i>, 2000, 30(2):191-4.\n <span class=\"pubmed-id\">10807164</span>\n </div>\n <div class=\"footnote\">2. Jenkins MA, Hendy J, Smith IL, “Evaluation of Hemoglobin A\n <sub>2</sub>\n Quantitation Assay and Hemoglobin Variant Screening by Capillary Electrophoresis,”<i>J Capillary\n Electrophor</i>, 1997, 4(3):137-43.\n <span class=\"pubmed-id\">9484661</span>\n </div>\n <div class=\"footnote\">3. Mario N, Baudin B, Aussel C, et al, “Capillary Isoelectric Focusing and\n High-Performance Cation-Exchange Chromatography Compared for Qualitative and Quantitative Analysis\n of Hemoglobin Variants,”<i>Clin Chem</i>, 1997, 43(11):2137-42.\n <span class=\"pubmed-id\">9365399</span>\n </div>\n <div class=\"footnote\">4. Craver RD, Abermanis JG, Warrier RP, et al, “Hemoglobin A\n <sub>2</sub>\n Levels in Healthy Persons, Sickle Cell Disease, Sickle Cell Trait, and β-Thalassemia by\n Capillary-Isoelectric Focusing,”<i>Am J Clin Pathol</i>, 1997, 107(1):88-91.\n <span class=\"pubmed-id\">8980373</span>\n </div>\n <div class=\"footnote\">5. Cotton F, Lin C, Fontaine B, et al, “Evaluation of a Capillary Electrophoresis\n Method for Routine Determination of Hemoglobins A\n <sub>2</sub>\n and F,”<i>Clin Chem</i>, 1999, 45(2):237-43.\n <span class=\"pubmed-id\">9931046</span>\n </div>\n <div class=\"footnote\">6. Cotton F, Gulbis B, Hansen V, et al, “Interference of Hemoglobin D in\n Hemoglobin A\n <sub>2</sub>\n Measurement by Cation-Exchange HPLC,”<i>Clin Chem</i>, 1999, 45(8 Pt 1):1317-8.\n <span class=\"pubmed-id\">10430811</span>\n </div>\n <div class=\"footnote\">7. Mario N, Baudin B, Bruneel A, et al, “Capillary Zone Electrophoresis for the\n Diagnosis of Congenital Hemoglobinopathies,”<i>Clin Chem</i>, 1999, 45(2):285-8.\n <span class=\"pubmed-id\">9931054</span>\n </div>\n <div class=\"footnote\">8. Weatherall DJ, “The Thalassemias,”<i>The Molecular Basis of Blood Diseases</i>,\n 3rd ed, Chapter 6, Stamatoyannopoulos G, Majerus PW, Perlmutter RM, et al, eds, Philadelphia, PA: WB\n Saunders Co, 2001, 183-226.\n </div>\n <div class=\"footnote\">9. Wasi P, Disthasongchan P, and Na-Nakorn S, “The Effect of Iron Deficiency on\n the Levels of Hemoglobins A\n <sub>2</sub>\n and E,”<i>J Lab Clin Med</i>, 1968, 71(1):85-91.\n <span class=\"pubmed-id\">5635011</span>\n </div>\n <div class=\"footnote\">10. Beris P, Darbellay R, Speiser D, et al, “De Novo Initiation Codon Mutation\n (ATG → ACG) of the β-Globin Gene Causing β-Thalassemia in a Swiss Family,”<i>Am J Hematol</i>, 1993,\n 42(3):248-53.\n <span class=\"pubmed-id\">8094943</span>\n </div>\n <div class=\"footnote\">11. Routy JP, Monte M, Beaulieu R, et al, “Increase of Hemoglobin A\n <sub>2</sub>\n in Human Immunodeficiency Virus-1-Infected Patients Treated With Zidovudine,”<i>Am J Hematol</i>,\n 1993, 43(2):86-90.\n <span class=\"pubmed-id\">8342556</span>\n </div>\n <div class=\"footnote\">12. Willekens FL, Bosch FH, Roerdinkholder-Stoelwinder B, et al, “Quantification\n of Loss of Haemoglobin Components From the Circulating Red Blood Cell<i>in vivo</i>,”<i>Eur J\n Haematol</i>, 1997, 58(4):246-50.\n <span class=\"pubmed-id\">9186535</span>\n </div>\n <div class=\"footnote\">13. Bosch FH, Werre JM, Roerdinkholder-Stoelwinder B, et al, “Characteristics of\n Red Cell Populations Fractionated With a Combination of Counterflow Centrifugation and Percoll\n Separation,”<i>Blood</i>, 1992, 79(1):254-60.\n <span class=\"pubmed-id\">1728314</span>\n </div>\n <div class=\"footnote\">14. Huisman TH, “Levels of Hb A\n <sub>2</sub>\n in Heterozygotes and Homozygotes for Beta-Thalassemia Mutations: Influence of Mutations in the CACCC\n and ATAAA Motifs of the Beta-Globin Gene Promoter,”<i>Acta Haematol</i>, 1997, 98(4):187-94.\n <span class=\"pubmed-id\">9401495</span>\n </div>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747165\" class=\"block rfs\">\n <div class=\"reference\">Chui DH, Fucharoen S, and Chan V, “Hemoglobin H Disease: Not Necessarily a Benign\n Disorder,”<i>Blood</i>, 2003, 101(3):791-800.\n <span class=\"pubmed-id\">12393486</span>\n </div>\n <div class=\"reference\">Lukens JN, “The Thalassemias and Related Disorders: Quantitative Disorders of\n Hemoglobin Synthesis,”<i>Wintrobe's Clinical Hematology</i>, 10th ed, Volume 1, Chapter 53, Lee GR,\n Foerster J, Lukens J, et al, eds, Baltimore, MD: Lippincott Williams &amp; Wilkins, 1999, 1405-48.\n </div>\n <div class=\"reference\">Steinberg MH and Adams JG 3d, “Hemoglobin A<sub>2</sub>: Origin, Evolution, and\n Aftermath,”<i>Blood</i>, 1991, 78(9):2165-77.\n <span class=\"pubmed-id\">1932737</span>\n </div>\n <div class=\"reference\">Thonglairoam V, Winichagoon P, Fucharoen S, et al, “Hemoglobin Constant Spring in\n Bangkok: Molecular Screening by Selective Enzymatic Amplification of the α<sub>2</sub>-Globin Gene,”\n <i>Am J Hematol</i>, 1991, 38(4):277-80.\n <span class=\"pubmed-id\">1746536</span>\n </div>\n </div>\n </mono>",
                "monoCreatedDate": "2006-03-15",
                "monoDocName": "Hemoglobine",
                "monoGlobalId": "34963",
                "monoId": "382436",
                "monoModifiedDate": "2010-04-17",
                "test": [
                    {
                        "class": "Test",
                        "id": 2
                    },
                    {
                        "class": "Test",
                        "id": 4
                    }
                ],
                "title": "Hematology"
            },
            "labTestsOnline": [
                {
                    "name": "Red Blood Cell Count",
                    "synonyms": "RBC Count; Erythrocyte Count; Red Count",
                    "relatedTests": "Complete Blood Count, Hemoglobin, Hematocrit, Blood Smear,\n Iron Tests, Reticulocyte Count, Vitamin B12 and Folate,\n Red Cell Indices, Bone Marrow Aspiration and Biopsy, G6PD,\n Erythropoietin",
                    "patientGeneralInfo": "Why Get Tested?\nTo evaluate the number of red blood cells (RBCs); used to screen for, help diagnose, or monitor conditions affecting red blood cells\n\nWhen to Get Tested?\nAs part of a complete blood count (CBC), during a health examination, or when your doctor suspects that you have a condition such as anemia (decreased number of RBCs) or polycythemia (increased number of RBCs)\n\nSample Required?\nA blood sample drawn from a vein in your arm or by a fingerstick (children and adults) or heelstick (newborns)\n\nTest Preparation Needed?\nNone",
                    "patientTestSample": "What is being tested?\nRed blood cells (RBCs), also called erythrocytes, are cells that circulate in the blood and carry oxygen throughout the body. The RBC count totals the number of red blood cells that are present in a person's sample of blood. It is one test among several that is included in a complete blood count (CBC), which is often used in the general evaluation of a person's health.\n\nBlood is made up of a few different types of cells suspended in fluid called plasma. In addition to RBCs, there are white blood cells (WBCs) and platelets. These cells are produced in the bone marrow and are released into the bloodstream as they mature. RBCs typically make up about 40% of the blood volume. RBCs contain hemoglobin, a protein that binds to oxygen and enables RBCs to carry oxygen from the lungs to the tissues and organs of the body. RBCs also help transport a small portion of carbon dioxide, a product of cell metabolism, from those tissues and organs back to the lungs where it is expelled.\n\nThe typical lifespan of an RBC is 120 days; thus the bone marrow must continually produce new RBCs to replace those that age and degrade or are lost through bleeding. There are a number of conditions that can affect the production of new RBCs and/or their lifespan, in addition to those conditions that may result in significant bleeding. These conditions may lead to a rise or drop in the RBC count.\n\nChanges in the RBC count usually mirror changes in the hematocrit and hemoglobin level. When the values of the RBC count, hematocrit, and hemoglobin decrease below the established reference interval, the person is said to be anemic. When the RBC and hemoglobin values increase above the normal range, the person is said to be polycythemic. Too few RBCs can affect the amount of oxygen reaching the tissues, while too many RBCs can make the blood thicker, causing slowed blood flow and related problems.\n\nHow is the sample collected for testing?\nA blood sample is obtained by inserting a needle into a vein in the arm or by collecting blood from a fingerstick (for children and adults) or a heelstick (for newborns).\n\nNOTE: If undergoing medical tests makes you or someone you care for anxious, embarrassed, or even difficult to manage, you might consider reading one or more of the following articles: Coping with Test Pain, Discomfort, and Anxiety, Tips on Blood Testing, Tips to Help Children through Their Medical Tests, and Tips to Help the Elderly through Their Medical Tests.\n\nAnother article, Follow That Sample, provides a glimpse at the collection and processing of a blood sample and throat culture.\n\nIs any test preparation needed to ensure the quality of the sample?\nNo test preparation is needed.",
                    "theTest": "How is it used?\nA red blood cell (RBC) count is typically ordered as part of a complete blood count (CBC) and may be used as part of a health checkup to screen for a variety of conditions. This test may also be used to help diagnose and/or monitor any number of diseases that affect the production or lifespan of the red blood cells.\n\nSome conditions affect the RBC production in the bone marrow and may cause an increase or decrease in the number of mature RBCs released into the blood circulation. Other conditions may affect the lifespan of RBCs in circulation, especially if the RBCs are deformed due to an inherited or acquired defect or abnormality. If there is increased destruction of RBCs (hemolysis) or loss of RBCs (bleeding) and the bone marrow is not able to produce new ones fast enough, then the overall number of RBCs will drop, resulting in an anemia.\n\nThis test can indicate if there is a problem with red blood cell production and/or lifespan, but it cannot determine the underlying cause. In addition to the full CBC, some other tests that may be performed at the same time or as follow up to establish a cause include a blood smear, reticulocyte count, iron studies, vitamin B12 and folate levels, and in more severe conditions, a bone marrow examination.\n\n\nWhen is it ordered?\nRBC counts are ordered as a part of the complete blood count (CBC), often as part of a routine physical or as part of a pre-surgical workup. When someone shows symptoms suggesting a disease that might affect red blood cell production, a CBC that includes the RBC count may help make a diagnosis. Some common signs and symptoms associated with anemia that generally lead to a doctor ordering a CBC are:\n\nWeakness or fatigue\nLack of energy\nPaleness\nSome signs and symptoms that may appear with a high RBC count include:\n\nDisturbed vision\nHeadache, dizziness\nFlushing\nEnlarged spleen\nThis test may also be performed on a regular basis to monitor people who have been diagnosed with conditions such as blood disorders, kidney disease, bleeding problems, chronic anemia, and polycythemia. Chemotherapy or radiation therapy often decreases bone marrow production of all the blood elements. Thus, a CBC would routinely be ordered when following these patients.\n\nWhat does the test result mean?\n\n\nSince an RBC count is performed as part of a CBC, results from other components are taken into consideration. A rise or drop in the RBC count must be interpreted in conjunction with other parameters, such as hemoglobin, hematocrit, reticulocyte count, and/or red blood cell indices. CBCs are performed with automated instrumentation and if results fall outside the normal reference intervals, a manual test, such as an examination of a blood smear under a microscope, may provide further clues to the cause of the abnormal results.\n\nAcute or chronic blood or red cell loss and diseases and conditions that decrease red cell production in the bone marrow will result in a low RBC count.\n\nSome causes of a low RBC count include:\n\nTrauma\nRBC destruction, for example hemolytic anemia caused by autoimmunity or defects in the red cell itself; the defects could be a hemoglobinopathy (e.g., sickle cell anemia), thalassemia, an abnormality in the RBC membrane (e.g., hereditary spherocytosis), or enzyme defect (e.g., G6PD deficiency).\nAcute or chronic bleeding from the digestive tract (e.g., ulcers, polyps, colon cancer) or other sites, such as the bladder or uterus (in women, heavy menstrual bleeding, for example)\nNutritional deficiency (e.g., iron deficiency, vitamin B12 or folate deficiency)\nBone marrow damage (e.g., toxin, radiation or chemotherapy, infection, drugs)\nBone marrow disorders such as leukemia, lymphoma, multiple myeloma, myelodysplasia, or other cancers that spread to the marrow\nChronic inflammatory disease or condition\nKidney failure—severe and chronic kidney diseases lead to decreased production of erythropoietin, a hormone produced by the kidneys that stimulates RBC production by the bone marrow.\nSome causes of an increased RBC count (polycythemia) include:\n\nPolycythemia vera—a rare disease in which the body produces excess RBCs inappropriately\nLung (pulmonary) disease—if someone is unable to breathe in and absorb sufficient oxygen, the body tries to compensate by producing more red blood cells.\nCongenital heart disease—with this condition, the heart is not able to pump blood efficiently, resulting in a decreased amount of oxygen getting to tissues. The body tries to compensate by producing more red blood cells.\nKidney tumor that produces excess erythropoietin\nSmoking\nGenetic causes (altered oxygen sensing, abnormality in hemoglobin oxygen release)\nDehydration—as the volume of fluid in the blood drops, the count of RBCs per volume of fluid artificially rises.\n^ Back to top\n\nIs there anything else I should know?\nA recent blood transfusion can affect results of an RBC count.\n\nAlteration of the number of RBCs is often transient and can be easily corrected and/or return to normal levels by eliminating the underlying condition.\n\nDuring pregnancy, body fluids tend to accumulate, thus decreasing the RBC count.\n\nLiving at high altitudes causes an increase in RBC count; this is your body's response to the decreased oxygen available at these heights.\n\nWomen tend to have slightly lower RBC counts than men.",
                    "commonQuestions": "1. How treatable are abnormal red blood cell counts?\nFirst, your doctor must determine the cause of your abnormal RBC count so he can prescribe appropriate treatment. For some anemias, treatment may include a dietary supplement or a change in your diet to include nutritional foods. In some instances, it may only require a change in your current medication. For more severe cases, treatment may involve transfusion with blood from a donor. For some, prescribing a drug to stimulate red cell production in the bone marrow may be required, especially in people who have received chemotherapy or radiation treatments.\n\n2. Can my RBC count be tested at my doctor’s office?\nMaybe. Some doctors' offices are equipped with laboratory instruments and staffed by trained laboratorians who are able to perform this test. \n\n3. Do diet and nutrition help keep RBCs at healthy levels?\nYes, to the extent that if you eat a well-balanced diet, you can prevent anemia due to a lack of iron, vitamin B12, or folate in the foods you eat. Sometimes use of a supplement is recommended if you are at risk of a vitamin deficiency. However, the most common cause of vitamin B12 deficiency is malabsorption, and the most common cause of iron deficiency is bleeding. These conditions and other RBC problems that are caused by diseases other than nutritional deficiencies will not be corrected by diet. \n\n4. Are there symptoms I should recognize if my RBCs are dangerously low or high?\nFatigue may indicate a low or high RBC count. Fainting, pallor, shortness of breath, dizziness, and/or altered mental status can also indicate a low RBC count. Disturbed vision, headache, and flushing may be present with increased numbers of RBCs."
                }
            ],
            "specialty": [
                {
                    "name": "Hematology"
                },
                {
                    "name": "Obstetrics"
                },
                {
                    "name": "Allergy and Immunology"
                },
                {
                    "name": "Rheumatology"
                },
                {
                    "name": "Cardiology"
                }
            ],
            "disease": [
                {
                    "name": "Liver disease"
                },
                {
                    "name": "Hyponatremia"
                },
                {
                    "name": "Diabetes"
                },
                {
                    "name": "Kidney disorders"
                }
            ],
            "condition": [
                {
                    "name": "Pregnancy"
                },
                {
                    "name": "Diabetes"
                },
                {
                    "name": "Osteoporosis"
                }
            ]
        },
        {
            "id": 3,
            "name": "Leukocytes",
            "localCode": "129",
            "loinc": {
                "class": "medilabcore.LOINC",
                "id": 4,
                "code": "6690-2",
                "component": "Leukocytes",
                "longName": "Leukocytes [#/​volume] in Blood by Automated count",
                "method": "Automated count",
                "name": "Leukocytes",
                "property": "NCnc",
                "scale": "Qn",
                "shortName": "Leukocytes",
                "system": "Bld",
                "time": "Pt"
            },
            "collectionTime": "From 8am to 12 pm",
            "servicePromise": "72 hours",
            "lexiCompLab": {
                "class": "medilabcore.LexiCompLab",
                "id": 1,
                "chapterId": "781",
                "chapterName": "Hematology",
                "chapterSections": "null",
                "chapterViewId": "5561",
                "mono": " <mono id=\"382423\" globalid=\"42126\" docName=\"Complete Blood Count\" createdDate=\"2006-03-15\"\n modifiedDate=\"2011-11-17\">\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746900\" class=\"block nam\">Complete Blood Count</div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746912\" class=\"sec_xr rftlist\">\n <ul>\n <li>\n <a href=\"urn:lims:s382452\">Complete Blood Count Differential and Peripheral Smear</a>\n </li>\n <li>\n <a href=\"urn:lims:s382460\">Reticulocyte Count</a>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746905\" class=\"block ovv\">\n <p style=\"text-indent:0em;display:inline\">The complete blood cell count (CBC) is a profile of tests\n rather than a single test. It is the standard, broadly inclusive, usually automated test for\n evaluation of white blood cells (WBC), red blood cells (RBC), and platelets (Plt). Complete blood\n count is among the most commonly ordered tests as it provides an overview of a patient's general\n health status.\n </p>\n <p style=\"text-indent:0em;margin-top:2em;\">Total white blood cell count (WBC) includes neutrophils (also\n known as polymorphonuclear cells, or PMNs), lymphocytes, monocytes, basophils, and eosinophils. The\n results help in the diagnosis and monitoring of infections, neoplastic conditions, and immunologic\n disease states. WBCs are measured in parts per cubic mm (mm<sup>3</sup>) and often expressed as (x\n 10<sup>9</sup>/L).\n </p>\n <p style=\"text-indent:0em;margin-top:2em;\">Hemoglobin (Hgb) and hematocrit (Hct), also known as the H&amp;H,\n help to assess oxygen carrying capacity. Hgb is a measurement of the oxygen-carrying protein in rbcs\n and is measured as g/dL. Hct, or packed red cell volume, is the percent of red cells contained in\n whole blood. It is typically three times the Hgb when RBCs are of normal size and contain normal\n amounts of hemoglobin.\n </p>\n <p style=\"text-indent:0em;margin-top:2em;\">Platelet count (Plt) helps assess bleeding, thrombotic, and\n neoplastic processes. It assists in the evaluation of bone marrow function, as well as the study of\n some diseases involving autoimmune mechanisms. Platelets are measured in parts per cubic mm (mm<sup>\n 3</sup>) and often expressed as (x 10<sup>9</sup>/L).\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746916\" class=\"block use\">\n <p style=\"text-indent:0em;\">\n <i>WBC:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Reaction to bacterial and viral infections</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Reaction to inflammation</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Evaluate myelopoiesis</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Diagnose/evaluate leukemic states</p>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Hgb and Hct:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Evaluate the adequacy of oxygen delivery to the tissues as is\n relates to hematologic (as opposed to cardiopulmonary) factors\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Evaluate state of hydration and dehydration</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify anemia</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify polycythemia</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify hemolytic disease of the newborn</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Manage chemotherapy decisions</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Provide the basis for calculations of blood cellular characteristics\n (MCV, MCH, MCHC, RDW) that reflect RBC size and shape, and which provide clues to the\n diagnosis of a variety of hematologic conditions (eg, anemia) (refer to Interpretative\n Information below)\n </p>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Platelets:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Evaluate, diagnose, and follow up bleeding disorders</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Evaluate purpura/petechiae</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify drug-induced thrombocytopenia</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify idiopathic thrombocytopenic purpura (ITP)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Identify disseminated intravascular coagulation (DIC)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Evaluate hypercoagulable states</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Manage chemotherapeutic decisions</p>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746904\" class=\"block tei\">\n <p style=\"text-indent:0em;display:inline\">White blood cell count (WBC); red blood cell count (RBC);\n hemoglobin (Hgb); hematocrit (Hct); mean corpuscular volume (MCV); mean corpuscular hemoglobin\n concentration (MCHC); red cell distribution (RDW); platelet count (Plt); mean platelet volume (MPV)\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746908\" class=\"block spe\">\n <p style=\"text-indent:0em;display:inline\">3 mL whole blood (2 mL minimum), usually peripheral</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746909\" class=\"block con\">\n <p style=\"text-indent:0em;display:inline\">Lavender top (EDTA) tube</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10070413\" class=\"block tec\">\n <p style=\"text-indent:0em;display:inline\">Primarily performed using automated equipment to analyze a\n simple venipuncture sample collected in a universal lavender (or purple) top tube containing EDTA as\n an anticoagulant.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746910\" class=\"block col\">\n <p style=\"text-indent:0em;display:inline\">Mix specimen 10 times by gentle inversion. If specimen is not\n brought to the laboratory immediately, refrigeration is required.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746911\" class=\"block sti\">\n <p style=\"text-indent:0em;display:inline\">EDTA-anticoagulated sample should be analyzed within 6 hours\n at room temperature and within 24 hours when stored at 4°C. Studies using the Cell-Dyn 3500 (Abbott\n Diagnostics, Mountain View, CA) found blood cell parameters stable for up to 24-48 hours\n (differential stable for 24 hours) at 4°C.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746918\" class=\"block met\">\n <p style=\"text-indent:0em;display:inline\">Varies considerably between institutions. Most laboratories\n have commercial high capacity multichannel instruments. The majority measure RBC and WBC parameters\n on the basis of changes in electrical impedance as cells and platelets are pulled through a tiny\n aperture. Some instruments count impulses as cells flow across a laser beam. These are highly\n automated devices with extensive computer processing of the electrical signals after analog/digital\n conversion. Accuracy (with proper standardization) and precision (usually in the 0.5% to 2% range)\n is significantly improved over older manual and semiautomated methods. Proper calibration is very\n important. Excellent correlation for all parameters (except basophils) has been shown across a wide\n spectrum of instruments.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10070416\" class=\"block daa\">\n <ul>\n <li>\n <p style=\"text-indent:0em;\">WBC</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">WBC 5-part differential: neutrophils, monocytes, lymphocytes,\n eosinophils, basophils\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RBC: Hct, Hgb</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RBC indices that describe the size and oxygen-carrying protein\n (hemoglobin) content of red blood cells and are used in the classification and diagnosis of\n anemia:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">MCV − mean corpuscular volume, most commonly used index</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RDW − red blood cell distribution width</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCHC − mean corpuscular hemoglobin concentration</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCH − mean corpuscular hemoglobin</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Platelet count</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Platelet indices that allow differentiation between hyperdestructive\n and hypoproliferative thrombocytopenia:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">PDW − platelet distribution width</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MPV − mean platelet volume</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Reticulocyte count and indices (not typically reported without a\n specific order to do so)\n </p>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746915\" class=\"block nof\">\n <p style=\"text-indent:0em;\">\n <i>WBC</i>\n (adults): 4.5-11.0 x 10<sup>9</sup>/L:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Diurnal variation present with lowest WBC level in morning and\n maximum level in afternoon\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">High levels of activity, emotional stress, or exercise (each\n associated with release of endogenous steroids) may increase WBC count, with increases of\n 2.0-5.0 x 10<sup>9</sup>/L common, and rises up to 30 x 10<sup>9</sup>/L possible\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">African-Americans individuals have consistently lower mean WBC\n counts than caucasians:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">0.6-1.3 x 10<sup>9</sup>/L lower on average between males\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">0.2-1.4 x 10<sup>9</sup>/L lower on average between females\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">WBC differential (adults):</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Neutrophils: 40% to 60%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Lymphocytes: 20% to 40%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Monocytes: 2% to 8%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Eosinophils: 1% to 4%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Basophils: 0.5% to 1%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Bands (young neutrophils): 0% to 3%</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <a href=\"http://www.pediatriccareonline.org/pco/ub/view/Pediatric-Drug-Lookup/153930/0/Normal_Laboratory_Values_for_Children\"\n target=\"_blank\">WBC normal values\n </a>\n for adults, young children, and infants can vary significantly.\n </p>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Hgb and Hct:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Adult female: 12-16 g/dL</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Adult male: 14-18 g/dL</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Males have consistently higher values than females</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Adults have\n <a href=\"http://www.pediatriccareonline.org/pco/ub/view/Pediatric-Drug-Lookup/153930/0/Normal_Laboratory_Values_for_Children\"\n target=\"_blank\">higher values\n </a>\n than children (except neonates, which have the highest values of all)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Red blood cell indices:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">MCV: 80–96 fL</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCH: 27–33 pg</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCHC: 33% to 36%</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RDW: 12% to 15%</p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Platelets:</i>\n 150-450 x 10<sup>9</sup>/L\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746914\" class=\"block crv\">\n <p style=\"text-indent:-2em;margin-left:4em;\">• WBC: &lt;2.5 x 10<sup>9</sup>/L or &gt;30 x 10<sup>\n 9</sup>/L\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;\">• Hemoglobin: &lt;6.0 g/dL or &gt;18.0 g/dL</p>\n <p style=\"text-indent:-2em;margin-left:4em;\">• Hematocrit: &lt;18% or &gt;54%</p>\n <p style=\"text-indent:-2em;margin-left:4em;\">• Platelets: &lt;20 x 10<sup>9</sup>/L or &gt;1000 x 10\n <sup>9</sup>/L\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10070417\" class=\"block interp-info\">\n <p style=\"text-indent:0em;\">\n <b>\n <i>WBC</i>\n </b>\n differential assists in:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Diagnosing bacterial infections (elevated WBC, often with\n predominance of neutrophils)\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">“Left shift” refers to the presence of increased numbers of\n mature neutrophils and immature neutrophil 'band' forms. May also be seen as a\n result of demargination due to physiologic stress or steroids.\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">&gt;75 % neutrophils</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">&gt;8% to 10% bands</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">&gt;7000 absolute neutrophil count (ANC) [(percent\n neutrophil) x (total WBC)]\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Diagnosing viral infections (decreased WBC, often with a\n predominance of lymphocytes)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Diagnosing malignancy such as leukemia (disproportionate\n number of one cell type, or a surplus of immature or 'blast' cells)\n </p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <b>\n <i>Red cell indices</i>\n </b>\n assist in diagnosing the underlying cause of anemia.\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">\n <i>MCV:</i>\n Mean corpuscular volume\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Most commonly used RBC index</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Reflects the average red blood cell size</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Calculated by dividing the hematocrit by the red blood cell\n count (number of red blood cells per liter)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Expressed in femtoliters per red cell (1 fL = 10\n <sup>-15</sup>\n L)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Categorizes red blood cells by size which is used to\n classify anemias:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Normocytic: Cells of normal size</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Microcytic: Cells smaller than normal size</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Macrocytic: Cells larger than normal size</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Increased with B\n <sub>12</sub>\n and folate deficiency; decreased with iron deficiency and thalassemia\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>MCH:</i>\n Mean corpuscular hemoglobin\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Hemoglobin amount per red blood cell</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCH = Hgb / RBC count</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Expressed in picograms per red cell (1 pg = 10\n <sup>-12</sup>\n g)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Mirrors MCV results</p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>MCHC:</i>\n Mean corpuscular hemoglobin concentration\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Amount of hemoglobin relative to the size of the red blood\n cell\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">MCHC = Hgb/Hct</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Expressed in grams per red cell (g/L)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Relates to the color of the cells which is used to classify\n anemias:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Normochromic: Cells with a normal concentration of\n Hgb\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Hypochromic: Cells with a lower than normal\n concentration, typically lighter in color with a large pale center\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <b>No</b>\n hyperchromic category as there is a physical limit to the amount of Hgb that\n will fit inside a RBC\n </p>\n </li>\n </ul>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>RDW:</i>\n RBC distribution width\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Measure of the variation of red blood cell size within a\n population\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Increased RDW indicates a mixed population of sizes</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Healthy blood cells are of a standard size, while in anemia\n and other disorders significant variation in cell size can occur\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RDW = standard deviation of erythrocyte volume distribution\n / MCV\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RDW results are often used together with MCV results to\n determine the cause of anemia, and are particularly helpful in differentiating an\n anemia of mixed causes from an anemia of a single cause.\n </p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;margin-top:2em;\"></p>\n <table rules=\"all\" border=\"1\" frame=\"border\">\n <caption style=\"text-align:center;\">Changes in RBC Indices With Disease</caption>\n <col align=\"left\" width=\"230\"/>\n <col align=\"center\" width=\"60\"/>\n <col align=\"center\" width=\"90\"/>\n <col align=\"center\" width=\"60\"/>\n <col align=\"center\" width=\"60\"/>\n <thead valign=\"bottom\">\n <tr>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Condition</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">MCV</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">MCH</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">MCHC</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">RDW</p>\n </th>\n </tr>\n </thead>\n <tfoot valign=\"top\">\n <tr>\n <td colspan=\"5\" align=\"left\">\n <p style=\"text-indent:0em;\">N=normal values</p>\n </td>\n </tr>\n </tfoot>\n <tbody valign=\"top\">\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Iron deficiency anemia</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Chronic inflammation</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Pernicious anemia</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N or high N</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">high N</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">B\n <sub>12</sub>\n / folate deficiency\n </p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N or high N</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">high N</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Hereditary spherocytosis</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N or ↓</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Hemolytic / aplastic anemia</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Anemia secondary to acute blood loss</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Polycythemia</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n <td align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\">\n <p style=\"text-indent:0em;\">Hemochromatosis</p>\n </td>\n <td align=\"center\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\">\n <p style=\"text-indent:0em;\">↑</p>\n </td>\n <td align=\"center\">\n <p style=\"text-indent:0em;\">N±</p>\n </td>\n </tr>\n </tbody>\n </table>\n <div class=\"text_table\">\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Table has been converted to the\n following text.\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:center;\">\n <b>Changes in RBC Indices With Disease</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Iron deficiency anemia:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Increased</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Chronic inflammation:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Pernicious anemia:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal or high normal</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: High normal</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Increased</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>B\n <sub>12</sub>\n / folate deficiency:\n </b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal or high normal</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: High normal</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Increased</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Hereditary spherocytosis:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Normal or decreased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Hemolytic / aplastic anemia:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Anemia secondary to acute blood loss:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Polycythemia:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n <b>Hemochromatosis:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCV: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCH: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• MCHC: Increased</p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• RDW: Normal ±</p>\n </div>\n <p style=\"text-indent:0em;\">\n <b>\n <i>Platelet indices</i>\n </b>\n allow differentiation between hyperdestructive and hypoproliferative thrombocytopenia:\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">\n <i>PDW:</i>\n Platelet distribution width\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Measure of the variation of platelet size within a\n population, which can be a sign of active platelet release\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Indicates whether platelets are normally distributed, and\n whether the measured cells are platelets at all\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>MPV:</i>\n Mean platelet volume\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Average size of platelets</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Elevated level indicates increased megakaryocyte shedding of\n platelets; decreased level seen in thrombocytopenia\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Significantly elevated MPV may indicate that production and/or\n destruction of platelets are increased, such as in ITP or leukemia\n </p>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746917\" class=\"block lim\">\n <p style=\"text-indent:0em;\">\n <i>WBC:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Falsely high WBC may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Presence of cryoglobulins/cryofibrinogen</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">EDTA-induced platelet aggregation or clumping (large clumps\n mistaken as WBCs)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Fibrin strands</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Presence of nucleated red blood cells</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Nonlysed red cells (eg, some cases of hemoglobinopathy)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Monoclonal proteins</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Cold agglutinins</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Capillary blood samples (may give WBC count 3% to 12% higher\n values than venous blood)\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Falsely low WBC counts may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Microclots or partial clotting of the specimen</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Loss of cell integrity due to prolonged storage</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Presence of fragile (apoptotic) white cells (eg, some cases\n of myelodysplastic syndrome)\n </p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Hemoglobin:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Falsely high Hgb may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Lipemic plasma, especially if chylomicronemia is present</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">White count is &gt;50 x 10<sup>9</sup>/L\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Falsely low Hgb may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Cold agglutinins which may cause spurious macrocytosis and\n low RBC count (RBC couplets are “seen” and processed as single cells by the\n detection circuitry)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Capillary blood samples (may give platelet count 3% to 12%\n lower values than venous blood)\n </p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Hematocrit:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Falsely high Hct may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Presence of cryoproteins</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">White count is &gt;50 x 10<sup>9</sup>/L\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Giant platelets (miscounted as RBCs)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">“Spun” (manual centrifuged) microhematocrits are ~3% higher\n (due to plasma trapping) compared to automated hematocrit levels\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Especially pronounced in polycythemia</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Accentuated when the cells are hypochromic and\n microcytic\n </p>\n </li>\n </ul>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Falsely low Hct may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Microcytosis</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">\n <i>In vitro</i>\n hemolysis\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Presence of autoagglutinins</p>\n </li>\n </ul>\n </li>\n </ul>\n <p style=\"text-indent:0em;\">\n <i>Platelets:</i>\n </p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Falsely high Plt may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">Cryoproteinemia (cryoglobulinemia)</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Hypertriglyceridemia (May cause increase in platelets of\n 2-40 x 10<sup>9</sup>/L, which can become significant with low platelet numbers)\n </p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">RBC or WBC fragments including fragmented fragile leukemic\n cells and neutrophil pseudoplatelets\n </p>\n </li>\n </ul>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Falsely low Plt may occur:</p>\n <ul>\n <li>\n <p style=\"text-indent:0em;\">EDTA-induced platelet clumping</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Platelet satellitism around neutrophils</p>\n </li>\n <li>\n <p style=\"text-indent:0em;\">Various platelet antigen/antibody reactions including\n antiplatelet with antiphospholipid antibodies (eg,\n <i>in vitro</i>\n clumping of IgM autoantibody against 78 kD platelet glycoprotein)\n </p>\n </li>\n </ul>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746913\" class=\"block cfr\">\n <p style=\"text-indent:0em;display:inline\">Improper tube; clotted specimen; hemolyzed specimen; dilution\n of blood with I.V. fluid\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746903\" class=\"list synlist\">\n <ul>\n <li>Blood Cell Profile</li>\n <li>Blood Count</li>\n <li>CBC</li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10070419\" class=\"list aptlist\">\n <ul>\n <li>H and H</li>\n <li>H&amp;H</li>\n <li>H+H</li>\n <li>Hemoglobin and Hematocrit</li>\n <li>Hemogram</li>\n <li>Hgb and Hct</li>\n <li>Leukocyte Count</li>\n <li>MCH</li>\n <li>MCHC</li>\n <li>MCV</li>\n <li>Mean Corpuscular Hemoglobin</li>\n <li>Mean Corpuscular Hemoglobin Concentration</li>\n <li>Mean Corpuscular Volume</li>\n <li>Mean Platelet Volume</li>\n <li>MPV</li>\n <li>PDW</li>\n <li>Platelet Count</li>\n <li>Platelet Volume Distribution</li>\n <li>RBC</li>\n <li>RDW</li>\n <li>Red Blood Cell Indicies</li>\n <li>Red Cell Count</li>\n <li>Red Cell Distribution Width</li>\n <li>Thrombocyte Count</li>\n <li>WBC</li>\n <li>White Blood Count</li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2746921\" class=\"block rfs\">\n <div class=\"reference\">American Academy of Pediatrics, “Normal Laboratory Values for Children,”\n http://www.pediatriccareonline.org/pco/ub/view/Pediatric-Drug-Lookup/153930/0/Normal_Laboratory_Values_for_Children\n (accessed 02/22/2010).\n </div>\n <div class=\"reference\">Bagby GC, “Leukopenia and Leukocytosis,”<i>Cecil Medicine</i>, 23rd ed, Chapter\n 173, Goldman L and Ausiello D, eds, Philadelphia, Pa: Saunders Elsevier, 2007.\n </div>\n <div class=\"reference\">Briggs C, “Quality Counts: New Parameters in Blood Cell Counting,”<i>Int J Lab\n Hematol</i>, 2009, 31(3):277-97.\n <span class=\"pubmed-id\">19452619</span>\n </div>\n <div class=\"reference\">Cheng CK, Chan J, Cembrowski GS, et al, “Complete Blood Count Reference Interval\n Diagrams Derived From NHANES III: Stratification by Age, Sex, and Race,”<i>Lab Hematol</i>, 2004,\n 10(1):42-53.\n <span class=\"pubmed-id\">15070217</span>\n </div>\n <div class=\"reference\">Gulati GL and Hyun BH, “The Automated CBC: A Current Perspective,”<i>Hematol\n Oncol Clin North Am</i>, 1994, 8(4):593-603.\n <span class=\"pubmed-id\">7961282</span>\n </div>\n <div class=\"reference\">Hoyer JD, “Leukocyte Differential,”<i>Mayo Clin Proc</i>, 1993, 68(10):1027-8.\n <span class=\"pubmed-id\">8412355</span>\n </div>\n <div class=\"reference\">Kjeldsberg CR, Elenitoba-Johnson K, Foucar K, et al,<i>Practical Diagnosis of\n Hematologic Disorders</i>, 3rd ed, Kjeldsberg CR, ed, Chicago, IL: ASCP Press, 2000.\n </div>\n <div class=\"reference\">“Laboratory Methods,”<i>Clinical Hematology and Fundamentals of Hemostasis</i>,\n 4th ed, Part V, Harmening DM, ed, Philadelphia, PA: FA Davis Co, 2002, 563-614.\n </div>\n <div class=\"reference\">Oosterhuis WP, Niessen RW, Bossuyt PM, et al, “Diagnostic Value of the Mean\n Corpuscular Volume in the Detection of Vitamin B\n <sub>12</sub>\n Deficiency,”<i>Scand J Clin Lab Invest</i>, 2000, 60(1):9-18.\n </div>\n <div class=\"reference\">Shapiro MF and Greenfield S, “The Complete Blood Count and Leukocyte Differential\n Count. An Approach to Their Rational Application,”<i>Ann Intern Med</i>, 1987, 106(1):65-74.\n <span class=\"pubmed-id\">3538968</span>\n </div>\n <div class=\"reference\">Sheridan BL, Lollo M, Howe S, et al, “Evaluation of the Roche Cobas Argos 5Diff\n Automated Haematology Analyzer With Comparison to a Coulter STK-S,”<i>Clin Lab Haematol</i>, 1994,\n 16(2):117-30.\n <span class=\"pubmed-id\">7955920</span>\n </div>\n <div class=\"reference\">“The Blood Count,”<i>Advanced Laboratory Methods in Haematology</i>, Part 1,\n Rowan RM, van Assendelft OW, and Preston FE, eds, London, UK: Arnold, 2002, 254.\n </div>\n </div>\n </mono>",
                "monoCreatedDate": "2006-03-15",
                "monoDocName": "Complete Blood Count",
                "monoGlobalId": "42126",
                "monoId": "382423",
                "monoModifiedDate": "2011-11-17",
                "test": [
                    {
                        "class": "Test",
                        "id": 3
                    },
                    {
                        "class": "Test",
                        "id": 1
                    }
                ],
                "title": "Hematology"
            },
            "labTestsOnline": [
                {
                    "name": "White Blood Cell Count",
                    "synonyms": "WBC Count; Leukocyte Count; White Count",
                    "relatedTests": "Complete Blood Count, Blood Smear, White Blood Cell Differential\n Count, Body Fluid Analysis, Bone Marrow Aspiration and Biopsy, Immunophenotyping,\n Chromosome Analysis",
                    "patientGeneralInfo": "Why Get Tested?\nTo screen for or diagnose a variety of conditions that can affect white blood cells (WBC) such as an infection, inflammation or a disease that affects the production or survival of WBCs; to monitor treatment of a blood disorder or to monitor therapy that is known to affect WBCs\n\nWhen to Get Tested?\nAs part of a complete blood count (CBC), when you have a routine health examination; when you have any number of signs and symptoms that may be related to a condition affecting WBCs such as infection, inflammation, or cancer; when you have a condition or are receiving treatment that is known to affect WBCs\n\nSample Required?\nA blood sample drawn from a vein in your arm or by a fingerstick (children and adults) or heelstick (newborns)\n\nTest Preparation Needed?\nNone",
                    "patientTestSample": "What is being tested?\nWhite blood cells, also called leukocytes, are cells that exist in the blood, the lymphatic system, and tissues and are an important part of the body's defense system. They help protect against infections and also have a role in inflammation, allergic responses, and protecting against cancer. The white blood cell (WBC) count totals the number of white blood cells in a person's sample of blood. It is one test among several that is included in a complete blood count (CBC), which is often used in the general evaluation of a person's health.\n\nBlood is made up of a few different types of cells suspended in fluid called plasma. In addition to WBCs, there are red blood cells and platelets. These cells are produced in the bone marrow and subsequently released into the blood to circulate. There are five types of WBCs, and each has a different function.\n\nThree types of WBCs are referred to as \"granulocytes\" because of the granules present in their cytoplasm. These granules release chemicals and other substances as part of the immune response. Granulocytes include neutrophils, which normally make up the largest number of circulating WBCs, eosinophils, and basophils. The other two types of WBCs are monocytes and lymphocytes. Lymphocytes are further divided into three subtypes: B lymphocytes that produces antibodies (also known as immunoglobulins), T lymphocytes, and natural killer cells (NK cells).\n\nWhen there is an infection or an inflammatory process somewhere in the body, the bone marrow produces more WBCs, releasing them into the blood, and through a complex process, they move to the site of infection or inflammation. As the condition resolves, the production of WBCs by the bone marrow subsides and the number of WBCs drops to normal levels again.\n\nIn addition to infections and inflammation, there are a number of conditions that can affect the production of WBCs by the bone marrow or the survival of WBCs in the blood, such as cancer or an immune disorder, resulting in either increased or decreased numbers of WBCs in the blood. The WBC count, along with the other components of the CBC, alerts the doctor to possible health issues. Results are often interpreted in conjunction with additional tests such as a WBC differential and a blood smear review. A differential may inform the doctor as to which type of WBC may be low or high, and a blood smear can reveal the presence of abnormal and/or immature populations of WBCs.\n\nIf results indicate a problem, a wide variety of other tests maybe performed in order to help determine the cause. A doctor will typically consider an individual's signs and symptoms, medical history, and results of a physical examination to decide what other tests may be necessary. For example, as needed, a bone marrow biopsy will be performed to evaluate the bone marrow status.\n\nHow is the sample collected for testing?\nThe blood sample is obtained by a needle placed in a vein in the arm or a fingerstick (for children and adults) or heelstick (for newborns).\n\nNOTE: If undergoing medical tests makes you or someone you care for anxious, embarrassed, or even difficult to manage, you might consider reading one or more of the following articles: Coping with Test Pain, Discomfort, and Anxiety, Tips on Blood Testing, Tips to Help Children through Their Medical Tests, and Tips to Help the Elderly through Their Medical Tests.\n\nAnother article, Follow That Sample, provides a glimpse at the collection and processing of a blood sample and throat culture.\n\nIs any test preparation needed to ensure the quality of the sample?\nNo test preparation is needed.",
                    "theTest": "How is it used?\nThe white blood cell count (WBC) is used as part of a full complete blood count (CBC) to:\n\nScreen for a wide range of diseases and conditions\nHelp diagnose an infection or inflammatory process; it also may be used to determine the presence of other diseases that affect WBCs such as allergies, leukemia or immune disorders, to name a few.\nMonitor the progression of conditions such as those named above; monitor the body's response to various treatments and/or to monitor bone marrow function; some treatments, such as radiation and chemotherapy, are known to affect white cells and may be monitored using WBC counts.\nSome diseases trigger a response by the immune system and cause an increase in the number of WBCs. Other conditions affect the production of WBCs by the bone marrow or the survival of WBCs in the circulation, resulting in either an increase or decrease in the number of circulating WBCs. A WBC count can indicate that there is a disease or condition affecting white blood cells, but it cannot determine the underlying cause. Several other tests may be performed at the same time or in follow up to an abnormal result to help make a diagnosis. Some of these additional tests may include a WBC differential, a blood smear review, or in severe conditions, a bone marrow examination. A differential may inform the doctor as to which type of WBC is low or high while a blood smear and/or bone marrow biopsy can reveal the presence of abnormal and/or immature populations of WBCs.\n\nWhen is it ordered?\nA WBC count is normally ordered as part of the complete blood count (CBC), which may be performed when an individual undergoes a routine health examination. The test may be done when someone has general signs and symptoms of an infection and/or inflammation such as:\n\nFever, chills\nBody aches, pain\nHeadache\nA variety of other signs and symptoms, depending on the site of suspected infection or inflammation\nTesting may be performed when there are signs and symptoms that the doctor thinks may be related to a blood disorder, autoimmune disorder, or an immune deficiency.\n\nA WBC may be ordered often and on a regular basis to monitor an individual who has been diagnosed with an infection, blood or immune disorder or another condition affecting WBCs. It may also been ordered periodically to monitor the effectiveness of treatment or when a particular therapy is known to affect WBCs, such as radiation or chemotherapy.\n\nWhat does the test result mean?\n\n\nA doctor will consider the results of a WBC count together with results from other components of the CBC as well as a number of other factors, such as physical examination, medical history, and signs and symptoms. A WBC count indicates an overall increase or decrease in the number of WBCs but does not determine the specific types of WBCs that are affected. For this, a differential must be performed and evaluated. The results of the differential will give further clues as to the cause of an increase or decrease. In addition, a blood smear may be performed to evaluate the appearance of white blood cells and to determine if abnormal and/or immature cells are present.\n\nA high white blood cell count, called leukocytosis, may result from a number of conditions and diseases. Some examples include:\n\nInfections, most commonly caused by bacteria and some viruses, less commonly by fungi or parasites\nInflammation or inflammatory conditions such as rheumatoid arthritis, vasculitis or inflammatory bowel disease\nLeukemia, myeloproliferative disorders\nConditions that result in tissue death (necrosis) such as trauma, burns, surgery or heart attack\nAllergic responses (e.g., allergies, asthma)\nIntense exercise\nSevere emotional or physical stress\nPregnancy in the final month and labor may be associated with increased WBC levels.\nA low white blood cell count, called leukopenia, can result from conditions such as:\n\nBone marrow damage (e.g., toxin, chemotherapy, radiation therapy, drugs)\nBone marrow disorders—the bone marrow does not produce sufficient WBCs (e.g., myelodysplastic syndrome, vitamin B12 or folate deficiency)\nLymphoma or other cancer that has spread (metastasized) to the bone marrow\nAutoimmune disorders—the body attacks and destroys its own WBCs (e.g., lupus)\nOverwhelming infections (e.g., sepsis)\nDiseases of the immune system, such as HIV, which destroy T lymphocytes\nWhen WBC counts are used for monitoring purposes, a series of WBC counts that continues to rise or fall to abnormal levels indicates that the condition or disease is getting worse. WBC counts that return to normal indicate improvement and/or successful treatment.\n\nIs there anything else I should know?\nIf you have had your spleen removed, you may have a persistent mild to moderate increase in WBC count.\n\nWBC counts are age-related. On average, normal newborns and infants have higher WBC counts than adults.\n\nIt is not uncommon for the elderly to fail to develop high WBC count (leukocytosis) as a response to infection.\n\nThere are many drugs that cause both increased and decreased WBC counts.",
                    "commonQuestions": "1. Can a WBC count be performed on a sample other than blood?\nYes. WBC counts may be performed on many different types of body fluids. A common reason that this is done is to more directly assess one area of the body that may be infected or inflamed. For example, if meningitis is suspected, then a WBC count plus differential may be performed on a sample of cerebrospinal fluid (CSF). Many other examples are listed in the article on Body Fluid Analysis.\n\n2. If I have an abnormal WBC count, what other tests might my doctor order?\nOther general tests to check your health may include a comprehensive metabolic panel (CMP). Depending on your signs, symptoms, medical history, physical exam and suspected condition, your doctor may choose to order a variety of other tests. A few general examples include:\n\n•\tBacterial infection: a culture of the affected area (e.g., urine culture, sputum culture, blood culture), strep test\n\n•\tViral infection: tests for mononucleosis, EBV\n\n•\tInflammation: CRP, ESR\n\n•\tAutoimmune diseases: ANA\n\n•\tAllergies: Allergy tests\n\n•\tLeukemia: Bone marrow biopsy, immunophenotyping (e.g., flow cytometry), chromosome analysis"
                }
            ],
            "specialty": [ ],
            "disease": [ ],
            "condition": [ ]
        },
        {
            "id": 4,
            "name": "Hemoglobin",
            "localCode": "124",
            "loinc": {
                "class": "medilabcore.LOINC",
                "id": 5,
                "code": "718-7",
                "component": "Hemoglobin",
                "longName": "Hemoglobin [Mass/​volume] in Blood",
                "method": "Automated count",
                "name": "Hemoglobin",
                "property": "NCnc",
                "scale": "Qn",
                "shortName": "Hemoglobin",
                "system": "Bld",
                "time": "Pt"
            },
            "collectionTime": "From 6am to 10am",
            "servicePromise": "48 hours",
            "lexiCompLab": {
                "class": "medilabcore.LexiCompLab",
                "id": 2,
                "chapterId": "781",
                "chapterName": "Hematology",
                "chapterSections": "null",
                "chapterViewId": "5561",
                "mono": "<mono id=\"382436\" globalid=\"34963\" docName=\"Hemoglobin A&lt;sub&gt;2&lt;/sub&gt;\" createdDate=\"2006-03-15\"\n modifiedDate=\"2010-04-17\">\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747148\" class=\"block nam\">Hemoglobin A\n <sub>2</sub>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747156\" class=\"sec_xr rftlist\">\n <ul>\n <li>\n <a href=\"urn:lims:s382452\">Complete Blood Count Differential and Peripheral Smear</a>\n </li>\n <li>\n <a href=\"urn:lims:s382483\">DNA-Probe Assay for Thalassemia (BeTha Gene Test)</a>\n </li>\n <li>\n <a href=\"urn:lims:s146388\">Hematology / Anemia Flowchart</a>\n </li>\n <li>\n <a href=\"urn:lims:s382437\">Hemoglobin Electrophoresis</a>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747153\" class=\"block ovv\">\n <p style=\"text-indent:0em;display:inline\">Hemoglobin A\n <sub>2</sub>\n (Hb A<sub>2</sub>) is a tetramer of α- and δ-globulin chains (α\n <sub>2</sub>\n δ<sub>2</sub>). Concentration fluctuates in the thalassemia syndromes and some acquired diseases.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747159\" class=\"block use\">\n <p style=\"text-indent:0em;display:inline\">Investigate microcytic anemia, for hemoglobinopathies,\n especially thalassemia, particularly beta-thalassemia trait\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747162\" class=\"block coi\">\n <p style=\"text-indent:0em;display:inline\">Recent blood transfusion</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747154\" class=\"block spe\">\n <p style=\"text-indent:0em;display:inline\">Whole blood</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747155\" class=\"block con\">\n <p style=\"text-indent:0em;display:inline\">Lavender top (EDTA) tube</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747161\" class=\"block met\">\n <p style=\"text-indent:0em;display:inline\">Electrophoresis, DEAE cellulose chromatography, high\n performance cation-exchange liquid chromatography (HPLC); radial immunodiffusion (RID) has also been\n used. Capillary electrophoresis\n <sup class=\"footnote-number\">2</sup>\n and capillary isoelectric focusing have been developed\n <sup class=\"footnote-number\">3,4,5</sup>\n and found to be rapid (under 15 minutes), precise (coefficient of variation &lt;2% to 6%),\n sensitive, and high resolution automated methods for determination of Hb variants, comparable to the\n use of HPLC but with lower cost.\n <sup class=\"footnote-number\">4</sup>\n Hb A\n <sub>2</sub>\n by capillary electrophoresis was not affected by presence of Hb S\n <sup class=\"footnote-number\">5</sup>\n or Hb D\n <sup class=\"footnote-number\">6</sup>\n as has been reported to occur with use of HPLC-variant β-thalassemia short program.\n <sup class=\"footnote-number\">1</sup>\n One study concluded that the use of capillary zone electrophoresis at alkaline pH with “dynamic\n coating” (which increases negative charge on the capillary surface with resultant high\n electro-osmotic flow and shortens analysis time) could replace HPLC for the screening of\n hemoglobinopathies.\n <sup class=\"footnote-number\">7</sup>\n Due to these partly method-based interpretive difficulties, each laboratory should have and utilize\n an alternate procedure, the application and performance of which is understood.\n <sup class=\"footnote-number\">6</sup>\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747158\" class=\"block nof\">\n <p style=\"text-indent:0em;display:inline\">The stable adult Hb A\n <sub>2</sub>\n level is 2.0% to 3.2% of total hemoglobin; ≤5 months: 0% to 2.5%; 6 months to 1 year: 1.5% to 2.9%.\n See table.\n </p>\n <table rules=\"all\" border=\"1\" frame=\"border\">\n <caption>Alterations in Hb A\n <sub>2</sub>\n in Various Disorders\n </caption>\n <col align=\"left\" width=\"80\"/>\n <col width=\"210\"/>\n <col align=\"left\" width=\"160\"/>\n <thead valign=\"bottom\">\n <tr>\n <th align=\"center\" valign=\"middle\"/>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Elevated</p>\n </th>\n <th align=\"center\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Reduced</p>\n </th>\n </tr>\n </thead>\n <tfoot valign=\"top\">\n <tr>\n <td colspan=\"3\" align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Adapted from Bunn HF and Forget BG,<i>Hemoglobin: Molecular,\n Genetic, and Clinical Aspects</i>, Philadelphia, PA: WB Saunders Co, 1986, 61-7.\n </p>\n </td>\n </tr>\n </tfoot>\n <tbody valign=\"middle\">\n <tr>\n <td align=\"left\" valign=\"middle\" rowspan=\"4\">\n <p style=\"text-indent:0em;\">Congenital</p>\n </td>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">β-thalassemia trait</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">α-thalassemia</p>\n </td>\n </tr>\n <tr>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">Unstable hemoglobin variants</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">δβ-thalassemia</p>\n </td>\n </tr>\n <tr>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">Sickle trait (AS)</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">δ-thalassemia</p>\n </td>\n </tr>\n <tr>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">SS with α-thalassemia</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">HPFH</p>\n </td>\n </tr>\n <tr>\n <td align=\"left\" valign=\"middle\" rowspan=\"2\">\n <p style=\"text-indent:0em;\">Acquired</p>\n </td>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">Megaloblastic anemias</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Iron deficiency</p>\n </td>\n </tr>\n <tr>\n <td valign=\"middle\">\n <p style=\"text-indent:0em;\">Hyperthyroidism</p>\n </td>\n <td align=\"left\" valign=\"middle\">\n <p style=\"text-indent:0em;\">Sideroblastic anemias</p>\n </td>\n </tr>\n </tbody>\n </table>\n <div class=\"text_table\">\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Table has been converted to the\n following text.\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:center;\">\n <b>Alterations in Hb A\n <sub>2</sub>\n in Various Disorders\n </b>\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">\n <b>Congenital:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• Elevated: β-thalassemia trait;\n unstable hemoglobin variants; sickle trait (AS); SS with α-thalassemia\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• Reduced: α-thalassemia;\n δβ-thalassemia; δ-thalassemia; HPFH\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">\n <b>Acquired:</b>\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• Elevated: Megaloblastic anemias;\n hyperthyroidism\n </p>\n <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">• Reduced: Iron deficiency;\n sideroblastic anemias\n </p>\n <p style=\"text-indent:0em;\">Adapted from Bunn HF and Forget BG,<i>Hemoglobin: Molecular, Genetic,\n and Clinical Aspects</i>, Philadelphia, PA: WB Saunders Co, 1986, 61-7.\n </p>\n </div>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747160\" class=\"block lim\">\n <p style=\"text-indent:0em;display:inline\">Blood transfusion prior to hemoglobin electrophoresis may make\n interpretation inconsistent. High levels of hemoglobin F usually are accompanied by lower levels of\n A<sub>2</sub>. Sickle cell trait range is from 1.7% to 4.5% hemoglobin A<sub>2</sub>. Presence of Hb\n S or Hb C will interfere with column chromatographic method.\n <sup class=\"footnote-number\">1</sup>\n Presence of Hb C interferes with routine electrophoretic method. Quantitation of Hb A\n <sub>2</sub>\n by densitometric scanning of electrophoretic pattern may result in misleading (high) results as this\n method is not uniformly reliable.\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747157\" class=\"block cfr\">\n <p style=\"text-indent:0em;display:inline\">Specimen clotted</p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747163\" class=\"block adi\">\n <p style=\"text-indent:0em;display:inline\">This test is done in many laboratories as part of the\n hemoglobin electrophoresis. Hemoglobin A\n <sub>2</sub>\n levels have special application to the diagnosis of beta-thalassemia trait, which may be present\n even though peripheral blood smear is normal. This reflects the underlying genetic spectrum of\n beta-thalassemia which in reality is a complex of multiple distinct (and some less distinct)\n conditions, the result of over 180 different mutations.\n <sup class=\"footnote-number\">8</sup>\n The microcytosis and other morphologic changes of beta-thalassemia trait must be differentiated from\n iron deficiency. Low MCV may include the majority of beta-thalassemia trait patients but does not\n differentiate iron deficient individuals. Low Hb A\n <sub>2</sub>\n levels occur in untreated iron deficiency. If iron deficiency occurs with beta-thalassemia, the Hb A\n <sub>2</sub>\n level may fall to within the normal range.\n <sup class=\"footnote-number\">9</sup>\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">The most definitive evidence for presence\n of beta-thalassemia trait is genetic (family study). A well documented report, however, indicates\n the occurrence of beta-thalassemia minor as a result of a spontaneous initiation codon mutation.\n <sup class=\"footnote-number\">10</sup>\n Offspring of a person with thalassemia major will have beta-thalassemia trait. Apart from such\n family/genetic studies (which are subject to practical difficulties) gene probes are the most\n definitive method for identifying beta-thalassemia trait. This method identifies “silent” carriers.\n See<a href=\"urn:lims:s382483\">DNA-Probe Assay for Thalassemia (BeTha Gene Test)</a>. Elevated\n percent Hb A\n <sub>2</sub>\n is the next best evidence for the diagnosis of beta-thalassemia trait. Sufficient criteria for the\n diagnosis of thalassemia trait are an elevated Hb A\n <sub>2</sub>\n percentage by a reliable method (Hb electrophoresis with elution and quantitation by\n spectrophotometry) or column chromatography (assuming Hb S, C, or an unstable hemoglobin are not\n present).\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Hb A\n <sub>2</sub>\n may be increased in megaloblastic anemia and may be decreased in sideroblastic anemia, Hb H disease,\n and erythroleukemia. Approximately 33% of zidovudine (AZT) treated human immunodeficiency virus-1\n positive individuals have elevated Hb A\n <sub>2</sub>\n levels.\n <sup class=\"footnote-number\">11</sup>\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Hemoglobin is gradually lost from the red\n blood cell during its lifespan. During the first half of the red cell lifespan Hb A and Hb A\n <sub>2</sub>\n decrease by glycation and carbamylation. During the second half of the lifespan, additional Hb and\n chemically altered forms are lost, overall total loss of 20%.\n <sup class=\"footnote-number\">12</sup>\n Red cells lose water and Hb with age producing changes in the red cell indices (decrease of 30% in\n MCV, increase of 15% in MCHC).\n <sup class=\"footnote-number\">13</sup>\n In addition to changes in red cell indices, these considerations have clinical application to the\n efficacy (expected improvement in Hb/Hct level) of red cell transfusions.\n <sup class=\"footnote-number\">12</sup>\n </p>\n <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">In a study of over 600 β-thalassemia\n heterozygotes (with multiple different underlying genetic mechanisms including 32 different base\n changes or frame shifts) severe cases (β°-thalassemia or β<sup>+</sup>-thalassemia) had Hb A\n <sub>2</sub>\n levels of 4.5% to 5.5%, mild β<sup>+</sup>-thalassemia had levels of 3.6% to 4.2%, while silent\n mutations had lower values. Homozygotes often had Hb A\n <sub>2</sub>\n levels of 10% or more but many cases had received transfusions such that A\n <sub>2</sub>\n values were not representative.\n <sup class=\"footnote-number\">14</sup>\n </p>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747151\" class=\"list synlist\">\n <ul>\n <li>Hb A\n <sub>2</sub>\n </li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747152\" class=\"list aptlist\">\n <ul>\n <li>Capillary Isoelectric Focusing</li>\n </ul>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747164\" class=\"block foo\">\n <div class=\"footnote\">1. Shokrani M, Terrell F, Turner EA, et al, “Chromatographic Measurements of\n Hemoglobin A\n <sub>2</sub>\n in Blood Samples That Contain Sickle Hemoglobin,”<i>Ann Clin Lab Sci</i>, 2000, 30(2):191-4.\n <span class=\"pubmed-id\">10807164</span>\n </div>\n <div class=\"footnote\">2. Jenkins MA, Hendy J, Smith IL, “Evaluation of Hemoglobin A\n <sub>2</sub>\n Quantitation Assay and Hemoglobin Variant Screening by Capillary Electrophoresis,”<i>J Capillary\n Electrophor</i>, 1997, 4(3):137-43.\n <span class=\"pubmed-id\">9484661</span>\n </div>\n <div class=\"footnote\">3. Mario N, Baudin B, Aussel C, et al, “Capillary Isoelectric Focusing and\n High-Performance Cation-Exchange Chromatography Compared for Qualitative and Quantitative Analysis\n of Hemoglobin Variants,”<i>Clin Chem</i>, 1997, 43(11):2137-42.\n <span class=\"pubmed-id\">9365399</span>\n </div>\n <div class=\"footnote\">4. Craver RD, Abermanis JG, Warrier RP, et al, “Hemoglobin A\n <sub>2</sub>\n Levels in Healthy Persons, Sickle Cell Disease, Sickle Cell Trait, and β-Thalassemia by\n Capillary-Isoelectric Focusing,”<i>Am J Clin Pathol</i>, 1997, 107(1):88-91.\n <span class=\"pubmed-id\">8980373</span>\n </div>\n <div class=\"footnote\">5. Cotton F, Lin C, Fontaine B, et al, “Evaluation of a Capillary Electrophoresis\n Method for Routine Determination of Hemoglobins A\n <sub>2</sub>\n and F,”<i>Clin Chem</i>, 1999, 45(2):237-43.\n <span class=\"pubmed-id\">9931046</span>\n </div>\n <div class=\"footnote\">6. Cotton F, Gulbis B, Hansen V, et al, “Interference of Hemoglobin D in\n Hemoglobin A\n <sub>2</sub>\n Measurement by Cation-Exchange HPLC,”<i>Clin Chem</i>, 1999, 45(8 Pt 1):1317-8.\n <span class=\"pubmed-id\">10430811</span>\n </div>\n <div class=\"footnote\">7. Mario N, Baudin B, Bruneel A, et al, “Capillary Zone Electrophoresis for the\n Diagnosis of Congenital Hemoglobinopathies,”<i>Clin Chem</i>, 1999, 45(2):285-8.\n <span class=\"pubmed-id\">9931054</span>\n </div>\n <div class=\"footnote\">8. Weatherall DJ, “The Thalassemias,”<i>The Molecular Basis of Blood Diseases</i>,\n 3rd ed, Chapter 6, Stamatoyannopoulos G, Majerus PW, Perlmutter RM, et al, eds, Philadelphia, PA: WB\n Saunders Co, 2001, 183-226.\n </div>\n <div class=\"footnote\">9. Wasi P, Disthasongchan P, and Na-Nakorn S, “The Effect of Iron Deficiency on\n the Levels of Hemoglobins A\n <sub>2</sub>\n and E,”<i>J Lab Clin Med</i>, 1968, 71(1):85-91.\n <span class=\"pubmed-id\">5635011</span>\n </div>\n <div class=\"footnote\">10. Beris P, Darbellay R, Speiser D, et al, “De Novo Initiation Codon Mutation\n (ATG → ACG) of the β-Globin Gene Causing β-Thalassemia in a Swiss Family,”<i>Am J Hematol</i>, 1993,\n 42(3):248-53.\n <span class=\"pubmed-id\">8094943</span>\n </div>\n <div class=\"footnote\">11. Routy JP, Monte M, Beaulieu R, et al, “Increase of Hemoglobin A\n <sub>2</sub>\n in Human Immunodeficiency Virus-1-Infected Patients Treated With Zidovudine,”<i>Am J Hematol</i>,\n 1993, 43(2):86-90.\n <span class=\"pubmed-id\">8342556</span>\n </div>\n <div class=\"footnote\">12. Willekens FL, Bosch FH, Roerdinkholder-Stoelwinder B, et al, “Quantification\n of Loss of Haemoglobin Components From the Circulating Red Blood Cell<i>in vivo</i>,”<i>Eur J\n Haematol</i>, 1997, 58(4):246-50.\n <span class=\"pubmed-id\">9186535</span>\n </div>\n <div class=\"footnote\">13. Bosch FH, Werre JM, Roerdinkholder-Stoelwinder B, et al, “Characteristics of\n Red Cell Populations Fractionated With a Combination of Counterflow Centrifugation and Percoll\n Separation,”<i>Blood</i>, 1992, 79(1):254-60.\n <span class=\"pubmed-id\">1728314</span>\n </div>\n <div class=\"footnote\">14. Huisman TH, “Levels of Hb A\n <sub>2</sub>\n in Heterozygotes and Homozygotes for Beta-Thalassemia Mutations: Influence of Mutations in the CACCC\n and ATAAA Motifs of the Beta-Globin Gene Promoter,”<i>Acta Haematol</i>, 1997, 98(4):187-94.\n <span class=\"pubmed-id\">9401495</span>\n </div>\n </div>\n <div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2747165\" class=\"block rfs\">\n <div class=\"reference\">Chui DH, Fucharoen S, and Chan V, “Hemoglobin H Disease: Not Necessarily a Benign\n Disorder,”<i>Blood</i>, 2003, 101(3):791-800.\n <span class=\"pubmed-id\">12393486</span>\n </div>\n <div class=\"reference\">Lukens JN, “The Thalassemias and Related Disorders: Quantitative Disorders of\n Hemoglobin Synthesis,”<i>Wintrobe's Clinical Hematology</i>, 10th ed, Volume 1, Chapter 53, Lee GR,\n Foerster J, Lukens J, et al, eds, Baltimore, MD: Lippincott Williams &amp; Wilkins, 1999, 1405-48.\n </div>\n <div class=\"reference\">Steinberg MH and Adams JG 3d, “Hemoglobin A<sub>2</sub>: Origin, Evolution, and\n Aftermath,”<i>Blood</i>, 1991, 78(9):2165-77.\n <span class=\"pubmed-id\">1932737</span>\n </div>\n <div class=\"reference\">Thonglairoam V, Winichagoon P, Fucharoen S, et al, “Hemoglobin Constant Spring in\n Bangkok: Molecular Screening by Selective Enzymatic Amplification of the α<sub>2</sub>-Globin Gene,”\n <i>Am J Hematol</i>, 1991, 38(4):277-80.\n <span class=\"pubmed-id\">1746536</span>\n </div>\n </div>\n </mono>",
                "monoCreatedDate": "2006-03-15",
                "monoDocName": "Hemoglobine",
                "monoGlobalId": "34963",
                "monoId": "382436",
                "monoModifiedDate": "2010-04-17",
                "test": [
                    {
                        "class": "Test",
                        "id": 2
                    },
                    {
                        "class": "Test",
                        "id": 4
                    }
                ],
                "title": "Hematology"
            },
            "labTestsOnline": [
                {
                    "name": "Hemoglobin",
                    "synonyms": "Hgb; Hb; H and H (Hemoglobin and Hematocrit)",
                    "relatedTests": "Complete Blood Count (CBC), Hematocrit, Red Blood Cell Count,\n Blood Smear, Iron Tests, Reticulocyte Count, Vitamin B12 and Folate,\n Red Cell Indices, Bone Marrow Aspiration and Biopsy, G6PD, Erythropoietin,\n Hemoglobin Variants",
                    "patientGeneralInfo": "Why Get Tested?\nTo evaluate the hemoglobin content of your blood as part of a general health checkup; to screen for and help diagnose conditions that affect red blood cells (RBCs); if you have anemia or polycythemia, to assess the severity of these conditions and to monitor response to treatment\n\nWhen to Get Tested?\nWith a hematocrit or as part of a complete blood count (CBC), which may be ordered as part of a general health screen; when your doctor suspects that you have a condition such as anemia (decreased hemoglobin) or polycythemia (increased hemoglobin); at regular intervals to monitor disease or response to treatment\n\nSample Required?\nA blood sample drawn from a vein in your arm or by a fingerstick (children and adults) or heelstick (newborns)\n\nTest Preparation Needed?\nNone",
                    "patientTestSample": "What is being tested?\nHemoglobin is the iron-containing protein found in all red blood cells (RBCs) that gives the cells their characteristic red color. Hemoglobin enables RBCs to bind to oxygen in the lungs and carry it to tissues and organs throughout the body. It also helps transport a small portion of carbon dioxide, a product of cell metabolism, from tissues and organs to the lungs where it is exhaled.\n\nThe hemoglobin test measures the amount of hemoglobin in a person's sample of blood. A hemoglobin level can be performed alone or with a hematocrit, a test that measures the proportion of blood that is made up of RBCs, to quickly evaluate an individual's red blood cells. Red blood cells, which make up about 40% (ranging 37-49%) of the blood's volume, are produced in the bone marrow and are released into the bloodstream after they mature. The typical lifespan of an RBC is 120 days, and the bone marrow must continually produce new RBCs to replace those that age and degrade or are lost through bleeding.\n\nSeveral diseases and conditions can affect RBCs and consequently the level of hemoglobin in the blood. In general, the hemoglobin level and hematocrit rise when the number of red blood cells increases. The hemoglobin level and hematocrit fall to less than normal when there is a drop in production of RBCs by the bone marrow, an increase in the destruction of RBCs, or if blood is lost due to bleeding. A drop in the RBC count, hemoglobin and hematocrit can result in anemia, a condition in which tissues and organs in the body do not get enough oxygen, causing fatigue and weakness. If too many RBCs are produced, the blood can become thickened, causing sluggish blood flow and related problems.\n\nHow is the sample collected for testing?\nA blood sample is obtained by inserting a needle into a vein in the arm or by a fingerstick (for children and adults) or heelstick (for newborns).\n\nNOTE: If undergoing medical tests makes you or someone you care for anxious, embarrassed, or even difficult to manage, you might consider reading one or more of the following articles: Coping with Test Pain, Discomfort, and Anxiety, Tips on Blood Testing, Tips to Help Children through Their Medical Tests, and Tips to Help the Elderly through Their Medical Tests.\n\nAnother article, Follow That Sample, provides a glimpse at the collection and processing of a blood sample and throat culture.\n\nIs any test preparation needed to ensure the quality of the sample?\nNo test preparation is needed.",
                    "theTest": "How is it used?\nThe hemoglobin test may be used to screen for, diagnose, or monitor a number of conditions and diseases that affect red blood cells (RBCs) and/or the amount of hemoglobin in blood. It is often used with a hematocrit as a quick evaluation of the number of RBCs or is performed as part of a complete blood count (CBC) as an integral part of a health evaluation. The test may be used to:\n\nScreen for, diagnose, and measure the severity of anemia (low RBCs, hemoglobin and hematocrit) or polycythemia (high RBCs, hemoglobin and hematocrit)\nMonitor the response to treatment of anemia or polycythemia\nHelp make decisions about blood transfusions or other treatments if the anemia is severe\nSome conditions affect RBC production in the bone marrow and may cause an increase or decrease in the number of mature RBCs released into the blood circulation. Other conditions may affect the lifespan of RBCs in the circulation. If there is increased destruction of RBCs (hemolysis) or loss of RBCs (bleeding) and/or the bone marrow is not able to produce new ones fast enough, then the overall number of RBCs and hemoglobin will drop, resulting in anemia.\n\nThis test can indicate if there is a problem with red blood cell production and/or lifespan, but it cannot determine the underlying cause. In addition to the full CBC, some other tests that may be performed at the same time or as follow up to establish a cause include a blood smear, reticulocyte count, iron studies, vitamin B12 and folate levels, and in more severe conditions, a bone marrow examination.\n\n^ Back to top\n\nWhen is it ordered?\nThe hemoglobin test may be ordered by itself, with a hematocrit, or as a part of the complete blood count (CBC) during a general health examination. These tests are also often ordered when a person has signs and symptoms of a condition affecting RBCs such as anemia or polycythemia.\n\nSome signs and symptoms of anemia include:\n\nWeakness or fatigue\nLack of energy\nFainting\nPaleness (pallor)\nShortness of breath\nSome signs and symptoms of polycythemia include:\n\nDisturbed vision\nDizziness\nHeadache\nFlushing\nEnlarged spleen\nThis test may be performed several times or on a regular basis when someone has been diagnosed with ongoing bleeding problems or chronic anemias or polycythemia to determine the effectiveness of treatment. It may also be ordered routinely on patients undergoing treatment for cancer that is known to affect the bone marrow.\n\n^ Back to top\n\nWhat does the test result mean?\n\n\nSince a hemoglobin level is often performed as part of a CBC, results from other components are taken into consideration. A rise or drop in the hemoglobin level must be interpreted in conjunction with other parameters, such as RBC count, hematocrit, reticulocyte count, and/or red blood cell indices. Age, gender, and race are other factors to be considered. In general, hemoglobin mirrors the results of the RBC count and hematocrit.\n\nSome causes of a low hemoglobin level include:\n\nExcessive destruction of red blood cells, for example, hemolytic anemia caused by autoimmunity or defects in the red cell itself; the defects could be hemoglobinopathy (e.g., sickle cell anemia), abnormalities in the RBC membrane (e.g., hereditary spherocytosis) or RBC enzyme (e.g., G6PD deficiency).\nDecreased hemoglobin production (e.g., thalassemia)\nAcute or chronic bleeding from the digestive tract (e.g., ulcers, polyps, colon cancer) or other sites, such as the bladder, uterus (in women, heavy menstrual bleeding, for example), or with severe trauma\nNutritional deficiencies such as iron, folate or B12 deficiency\nDamage to the bone marrow from, for example, a toxin, radiation or chemotherapy, infection or drugs\nKidney failure—severe and chronic kidney diseases lead to decreased production of erythropoietin, a hormone produced by the kidneys that stimulates RBC production by the bone marrow\nChronic inflammatory diseases or conditions\nBone marrow disorders such as aplastic anemia, myelodysplastic syndrome, or cancers such as leukemia, lymphoma, multiple myeloma, or other cancers that spread to the marrow\nSome causes of a high hemoglobin level include:\n\nPolycythemia vera—a rare disease in which the body produces excess RBCs inappropriately\nLung (pulmonary) disease—if someone is unable to breathe in and absorb sufficient oxygen, the body tries to compensate by producing more red blood cells\nCongenital heart disease—in some forms, there is an abnormal connection between the two sides of the heart, leading to reduced oxygen levels in the blood. The body tries to compensate by producing more red blood cells.\nKidney tumors that produce excess erythropoietin\nSmoking—heavy smokers have higher hemoglobin levels than nonsmokers.\nGenetic causes (altered oxygen sensing, abnormality in hemoglobin oxygen release)\nLiving at high altitudes (a compensation for decreased oxygen in the air)\nDehydration—as the volume of fluid in the blood drops, the hemoglobin artificially rises.\n^ Back to top\n\nIs there anything else I should know?\nA recent blood transfusion can affect a person's hemoglobin level.\n\nHemoglobin decreases slightly during normal pregnancy.",
                    "commonQuestions": "1. Can I test my hemoglobin at home?\nYes, there are some home tests currently available that have been approved by the U.S. Food and Drug Administration (FDA). Home testing offers many benefits, but it's also important to recognize the potential tradeoffs between quality and convenience and to take steps to protect yourself against the possibility of false results, and your own lack of training. Talk to your doctor about this type of testing and consult her about any questions or concerns you may have. For more about these tests, see the article With Home Testing, Consumers Take Charge of Their Health.\n^ Back to top\n\n2. Is anyone at greater risk of abnormal hemoglobin levels?\nWomen of childbearing age tend to have lower hemoglobin levels than men due to loss of iron and blood during menstrual periods and increased need for iron during pregnancy. Others who are at greater risk of a low hemoglobin level (anemia) include people with poor nutrition and diets low in iron or vitamins, people who have undergone surgery or have been severely injured, people with chronic conditions such as kidney disease, cancer, HIV/AIDS, inflammatory bowel disease, chronic infection or chronic inflammatory conditions (e.g., rheumatoid arthritis). Someone who has family members with a genetic cause of anemia, such as sickle cell or thalassemia, also has a higher risk of having the condition and a higher risk of anemia.\n^ Back to top\n\n3. Are there warning signs for abnormally low hemoglobin levels?\nSome warning signs are fatigue, fainting, pallor, and shortness of breath.\n^ Back to top\n\n4. Can a healthy diet and nutrition help keep optimal hemoglobin levels?\nYes, to the extent that if you eat a well-balanced diet, you can prevent anemia due to a lack of iron, vitamin B12, or folate in the foods you eat. Sometimes use of a supplement is recommended if you are at risk of a vitamin deficiency. However, the most common cause of vitamin B12 deficiency is malabsorption, and the most common cause of iron deficiency is bleeding. These conditions and other RBC problems that are caused by diseases other than nutritional deficiencies cannot be corrected by diet."
                }
            ],
            "specialty": [ ],
            "disease": [ ],
            "condition": [ ]
        }
    ]

}